,id,Procedure type,Document type,Language code,Display code,Name,parent_id,Mandatory
1,1,CAP,SmPC,bg,,КРАТКА ХАРАКТЕРИСТИКА НА ПРОДУКТА,,True
2,2,CAP,SmPC,bg,,qТози лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. От медицинските специалисти се изисква да съобщават всяка подозирана нежелана реакция. За начина на съобщаване на нежелани реакции вижте точка 4.8,1.0,False
3,3,CAP,SmPC,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,1.0,True
4,4,CAP,SmPC,bg,2,КАЧЕСТВЕН И КОЛИЧЕСТВЕН СЪСТАВ,1.0,True
5,5,CAP,SmPC,bg,2.1,Общо описание,4.0,False
6,6,CAP,SmPC,bg,2.2,Качествен и количествен състав,4.0,False
7,7,CAP,SmPC,bg,,Помощно(и) вещество(а) с известно действие,6.0,False
8,8,CAP,SmPC,bg,3,ЛЕКАРСТВЕНА ФОРМА,1.0,True
9,9,CAP,SmPC,bg,4,КЛИНИЧНИ ДАННИ,1.0,True
10,10,CAP,SmPC,bg,4.1,Терапевтични показания ,9.0,True
11,11,CAP,SmPC,bg,4.2,Дозировка и начин на приложение,9.0,True
12,12,CAP,SmPC,bg,,Дозировка,11.0,True
13,13,CAP,SmPC,bg,,Педиатрична популация,12.0,True
14,14,CAP,SmPC,bg,,Начин на приложение,11.0,True
15,15,CAP,SmPC,bg,,"Предпазни мерки, които трябва да бъдат взети преди работа със или приложение на лекарствения продукт",14.0,False
16,16,CAP,SmPC,bg,4.3,Противопоказания,9.0,True
17,17,CAP,SmPC,bg,4.4,Специални предупреждения и предпазни мерки при употреба,9.0,True
18,18,CAP,SmPC,bg,,Проследимост,17.0,False
19,19,CAP,SmPC,bg,,Педиатрична популация,17.0,False
20,20,CAP,SmPC,bg,4.5,Взаимодействие с други лекарствени продукти и други форми на взаимодействие,9.0,True
21,21,CAP,SmPC,bg,,Педиатрична популация,20.0,False
22,22,CAP,SmPC,bg,4.6,"Фертилитет, бременност и кърмене",9.0,True
23,23,CAP,SmPC,bg,,Бременност,22.0,False
24,24,CAP,SmPC,bg,,Кърмене,22.0,False
25,25,CAP,SmPC,bg,,Фертилитет,22.0,False
26,26,CAP,SmPC,bg,4.7,Ефекти върху способността за шофиране и работа с машини,9.0,True
27,27,CAP,SmPC,bg,4.8,Нежелани лекарствени реакции,9.0,True
28,28,CAP,SmPC,bg,,Педиатрична популация,27.0,False
29,29,CAP,SmPC,bg,,Съобщаване на подозирани нежелани реакции,27.0,True
30,30,CAP,SmPC,bg,4.9,Предозиране,9.0,True
31,31,CAP,SmPC,bg,,Педиатрична популация,30.0,False
32,32,CAP,SmPC,bg,5,ФАРМАКОЛОГИЧНИ СВОЙСТВА,1.0,True
33,33,CAP,SmPC,bg,5.1,Фармакодинамични свойства,32.0,True
34,34,CAP,SmPC,bg,,Механизъм на действие,33.0,False
35,35,CAP,SmPC,bg,,Фармакодинамични ефекти,33.0,False
36,36,CAP,SmPC,bg,,Клинична ефикасност и безопасност,33.0,False
37,37,CAP,SmPC,bg,,Педиатрична популация,33.0,False
38,38,CAP,SmPC,bg,5.2,Фармакокинетични свойства,32.0,True
39,39,CAP,SmPC,bg,,Абсорбция,38.0,False
40,40,CAP,SmPC,bg,,Разпределение,38.0,False
41,41,CAP,SmPC,bg,,Биотрансформация,38.0,False
42,42,CAP,SmPC,bg,,Елиминиране,38.0,False
43,43,CAP,SmPC,bg,,Линейност/нелинейност,38.0,False
44,44,CAP,SmPC,bg,,Връзка(и) фармакокинетика-фармакодинамика,38.0,False
45,45,CAP,SmPC,bg,5.3,Предклинични данни за безопасност,32.0,True
46,46,CAP,SmPC,bg,,Оценка на риска за околната среда (ERA),45.0,False
47,47,CAP,SmPC,bg,6,ФАРМАЦЕВТИЧНИ ДАННИ,1.0,True
48,48,CAP,SmPC,bg,6.1,Списък на помощните вещества,47.0,True
49,49,CAP,SmPC,bg,6.2,Несъвместимости,47.0,True
50,50,CAP,SmPC,bg,6.3,Срок на годност,47.0,True
51,51,CAP,SmPC,bg,6.4,Специални условия на съхранение,47.0,True
52,52,CAP,SmPC,bg,6.5,"Вид и съдържание на опаковката <и специални приспособления за употреба, приложение или имплантиране>",47.0,True
53,53,CAP,SmPC,bg,6.6,Специални предпазни мерки при изхвърляне <и работа>,47.0,True
54,54,CAP,SmPC,bg,,Употреба при педиатричната популация,53.0,False
55,55,CAP,SmPC,bg,7,ПРИТЕЖАТЕЛ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True
56,56,CAP,SmPC,bg,8,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True
57,57,CAP,SmPC,bg,9,ДАТА НА ПЪРВО РАЗРЕШАВАНЕ/ПОДНОВЯВАНЕ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1.0,True
58,58,CAP,SmPC,bg,10,ДАТА НА АКТУАЛИЗИРАНЕ НА ТЕКСТА,1.0,True
59,59,CAP,SmPC,bg,11,ДОЗИМЕТРИЯ,1.0,False
60,60,CAP,SmPC,bg,12,ИНСТРУКЦИИ ЗА ПРИГОТВЯНЕ НА РАДИОФАРМАЦЕВТИЦИ ,1.0,False
1,1001,CAP,AnnexII,bg,,ПРИЛОЖЕНИЕ II,,True
2,1002,CAP,AnnexII,bg,A.,"<ПРОИЗВОДИТЕЛ(И) НА БИОЛОГИЧНО АКТИВНОТО(ИТЕ) ВЕЩЕСТВО(А) И>ПРОИЗВОДИТЕЛ(И), ОТГОВОРЕН(НИ) ЗА ОСВОБОЖДАВАНЕ НА ПАРТИДИ ",1001.0,True
3,1003,CAP,AnnexII,bg,,Име и адрес на производителя(ите) на биологично активното(ите) вещество(а),1002.0,False
4,1004,CAP,AnnexII,bg,,"Име и адрес на производителя(ите), отговорен(ни) за освобождаване на партидите",1002.0,True
5,1005,CAP,AnnexII,bg,Б.,УСЛОВИЯ ИЛИ ОГРАНИЧЕНИЯ ЗА ДОСТАВКА И УПОТРЕБА,1001.0,True
6,1006,CAP,AnnexII,bg,,Официално освобождаване на партиди,1005.0,False
7,1007,CAP,AnnexII,bg,В.,ДРУГИ УСЛОВИЯ И ИЗИСКВАНИЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,1001.0,True
8,1008,CAP,AnnexII,bg,,Периодични актуализирани доклади за безопасност (ПАДБ),1007.0,True
9,1009,CAP,AnnexII,bg,Г.,УСЛОВИЯ ИЛИ ОГРАНИЧЕНИЯ ЗА БЕЗОПАСНА И ЕФЕКТИВНА УПОТРЕБА НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,1001.0,True
10,1010,CAP,AnnexII,bg,,План за управление на риска (ПУР),1009.0,True
11,1011,CAP,AnnexII,bg,,Допълнителни мерки за свеждане на риска до минимум,1009.0,False
12,1012,CAP,AnnexII,bg,,Задължение за провеждане на мерки след разрешаване за употреба,1009.0,False
13,1013,CAP,AnnexII,bg,Д.,КОНКРЕТНО ЗАДЪЛЖЕНИЕ ЗА ИЗПЪЛНЕНИЕ НА МЕРКИ СЛЕД <РАЗРЕШАВАНЕ ЗА УПОТРЕБА ПОД УСЛОВИЕ> <РАЗРЕШАВАНЕ ЗА УПОТРЕБА ПРИ ИЗВЪНРЕДНИ ОБСТОЯТЕЛСТВА>,1001.0,False
1,2001,CAP,Labelling,bg,,ДАННИ ВЪРХУ ОПАКОВКАТА,,True
2,2002,CAP,Labelling,bg,,"ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖА <ВТОРИЧНАТА ОПАКОВКА> <И> <ПЪРВИЧНАТА ОПАКОВКА>",2001.0,True
3,2003,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,2002.0,True
4,2004,CAP,Labelling,bg,2,ОБЯВЯВАНЕ НА АКТИВНОТО(ИТЕ) ВЕЩЕСТВО(А),2002.0,True
5,2005,CAP,Labelling,bg,3,СПИСЪК НА ПОМОЩНИТЕ ВЕЩЕСТВА,2002.0,True
6,2006,CAP,Labelling,bg,4,ЛЕКАРСТВЕНА ФОРМА И КОЛИЧЕСТВО В ЕДНА ОПАКОВКА,2002.0,True
7,2007,CAP,Labelling,bg,5,НАЧИН НА ПРИЛОЖЕНИЕ И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,2002.0,True
8,2008,CAP,Labelling,bg,6,"СПЕЦИАЛНО ПРЕДУПРЕЖДЕНИЕ, ЧЕ ЛЕКАРСТВЕНИЯТ ПРОДУКТ ТРЯБВА ДА СЕ СЪХРАНЯВА НА МЯСТО ДАЛЕЧЕ ОТ ПОГЛЕДА И ДОСЕГА НА ДЕЦА ",2002.0,True
9,2009,CAP,Labelling,bg,7,"ДРУГИ СПЕЦИАЛНИ ПРЕДУПРЕЖДЕНИЯ, АКО Е НЕОБХОДИМО",2002.0,True
10,2010,CAP,Labelling,bg,8,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2002.0,True
11,2011,CAP,Labelling,bg,9,СПЕЦИАЛНИ УСЛОВИЯ НА СЪХРАНЕНИЕ,2002.0,True
12,2012,CAP,Labelling,bg,10,"СПЕЦИАЛНИ ПРЕДПАЗНИ МЕРКИ ПРИ ИЗХВЪРЛЯНЕ НА НЕИЗПОЛЗВАНА ЧАСТ ОТ ЛЕКАРСТВЕНИТЕ ПРОДУКТИ ИЛИ ОТПАДЪЧНИ МАТЕРИАЛИ ОТ ТЯХ, АКО СЕ ИЗИСКВАТ ТАКИВА",2002.0,True
13,2013,CAP,Labelling,bg,11,ИМЕ И АДРЕС НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2002.0,True
14,2014,CAP,Labelling,bg,12,НОМЕР(А) НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2002.0,True
15,2015,CAP,Labelling,bg,13,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2002.0,True
16,2016,CAP,Labelling,bg,14,НАЧИН НА ОТПУСКАНЕ,2002.0,True
17,2017,CAP,Labelling,bg,15,УКАЗАНИЯ ЗА УПОТРЕБА,2002.0,True
18,2018,CAP,Labelling,bg,16,ИНФОРМАЦИЯ НА БРАЙЛОВА АЗБУКА,2002.0,True
19,2019,CAP,Labelling,bg,17,УНИКАЛЕН ИДЕНТИФИКАТОР — ДВУИЗМЕРЕН БАРКОД,2002.0,True
20,2020,CAP,Labelling,bg,18,УНИКАЛЕН ИДЕНТИФИКАТОР — ДАННИ ЗА ЧЕТЕНЕ ОТ ХОРА,2002.0,True
21,2021,CAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ БЛИСТЕРИТЕ И ЛЕНТИТЕ",2001.0,True
22,2022,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКТ,2021.0,True
23,2023,CAP,Labelling,bg,2,ИМЕ НА ПРИТЕЖАТЕЛЯ НА РАЗРЕШЕНИЕТО ЗА УПОТРЕБА,2021.0,True
24,2024,CAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2021.0,True
25,2025,CAP,Labelling,bg,4,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2021.0,True
26,2026,CAP,Labelling,bg,5,ДРУГО,2021.0,True
27,2027,CAP,Labelling,bg,,"МИНИМУМ ДАННИ, КОИТО ТРЯБВА ДА СЪДЪРЖАТ МАЛКИТЕ ЕДИНИЧНИ ПЪРВИЧНИ ОПАКОВКИ",2001.0,True
28,2028,CAP,Labelling,bg,1,ИМЕ НА ЛЕКАРСТВЕНИЯ ПРОДУКT И ПЪТ(ИЩА) НА ВЪВЕЖДАНЕ,2027.0,True
29,2029,CAP,Labelling,bg,2,НАЧИН НА ПРИЛОЖЕНИЕ,2027.0,True
30,2030,CAP,Labelling,bg,3,ДАТА НА ИЗТИЧАНЕ НА СРОКА НА ГОДНОСТ,2027.0,True
31,2031,CAP,Labelling,bg,4,"ПАРТИДЕН НОМЕР<, КОДОВЕ НА ДАРЕНИЕТО И НА ПРОДУКТА>",2027.0,True
32,2032,CAP,Labelling,bg,5,"СЪДЪРЖАНИЕ КАТО МАСА, ОБЕМ ИЛИ ЕДИНИЦИ",2027.0,True
33,2033,CAP,Labelling,bg,6,ДРУГО,2027.0,True
1,3001,CAP,Package leaflet,bg,, ЛИСТОВКА,,True
2,3002,CAP,Package leaflet,bg,,"q Този лекарствен продукт подлежи на допълнително наблюдение. Това ще позволи бързото установяване на нова информация относно безопасността. Можете да дадете своя принос като съобщите всяка нежелана реакция, която сте получили. За начина на съобщаване на нежелани реакции вижте края на точка 4. ",3001.0,False
3,3003,CAP,Package leaflet,bg,,Какво съдържа тази листовка,3001.0,True
4,3004,CAP,Package leaflet,bg,1,Какво представлява Х и за какво се използва,3001.0,True
5,3005,CAP,Package leaflet,bg,2,"Какво трябва да знаете, преди да <приемете> <използвате> Х",3001.0,True
6,3006,CAP,Package leaflet,bg,,Не <приемайте> <използвайте> X,3005.0,True
7,3007,CAP,Package leaflet,bg,,Предупреждения и предпазни мерки,3005.0,True
8,3008,CAP,Package leaflet,bg,,Деца <и юноши>,3005.0,True
9,3009,CAP,Package leaflet,bg,,Други лекарства и Х,3005.0,True
10,3010,CAP,Package leaflet,bg,,"X с <храна> <и> <,> <напитки> <и> <алкохол>",3005.0,True
11,3011,CAP,Package leaflet,bg,,"Бременност <и> <,> кърмене <и фертилитет>",3005.0,True
12,3012,CAP,Package leaflet,bg,,Шофиране и работа с машини,3005.0,True
13,3013,CAP,Package leaflet,bg,,X съдържа {име на помощното(ите) вещество(а)},3005.0,False
14,3014,CAP,Package leaflet,bg,3,Как да <приемате> <използвате> Х,3001.0,True
15,3015,CAP,Package leaflet,bg,,Употреба при деца <и юноши>,3014.0,False
16,3016,CAP,Package leaflet,bg,,Ако сте <приели> <използвали> повече от необходимата доза X,3014.0,False
17,3017,CAP,Package leaflet,bg,,Ако сте пропуснали да <приемете> <използвате> X,3014.0,False
18,3018,CAP,Package leaflet,bg,,Ако сте спрели <приема> <употребата> на X,3014.0,False
19,3019,CAP,Package leaflet,bg,4,Възможни нежелани реакции,3001.0,True
20,3020,CAP,Package leaflet,bg,,Допълнителни нежелани реакции при деца <и юноши,3019.0,False
21,3021,CAP,Package leaflet,bg,,Съобщаване на нежелани реакции,3019.0,True
22,3022,CAP,Package leaflet,bg,5,Как да съхранявате X,3001.0,True
23,3023,CAP,Package leaflet,bg,6,Съдържание на опаковката и допълнителна информация,3001.0,True
24,3024,CAP,Package leaflet,bg,,Какво съдържа X,3023.0,True
25,3025,CAP,Package leaflet,bg,,Как изглежда X и какво съдържа опаковката ,3023.0,True
26,3026,CAP,Package leaflet,bg,,Притежател на разрешението за употреба и производител,3023.0,True
27,3027,CAP,Package leaflet,bg,,"За допълнителна информация относно това лекарствo, моля, свържете се с локалния представител на притежателя на разрешението за употреба:",3023.0,False
28,3028,CAP,Package leaflet,bg,,Дата на последно преразглеждане на листовката <{ММ /ГГГГ}> <{месец ГГГГ}>.,3023.0,True
29,3029,CAP,Package leaflet,bg,,Други източници на информация,3023.0,False
30,3030,CAP,Package leaflet,bg,,Посочената по-долу информация е предназначена само за медицински специалисти:,3001.0,False
1,4001,CAP,SmPC,cs,,SOUHRN ÚDAJŮ O PŘÍPRAVKU,,True
2,4002,CAP,SmPC,cs,,"qTento léčivý přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Žádáme zdravotnické pracovníky, aby hlásili jakákoli podezření na nežádoucí účinky. Podrobnosti o hlášení nežádoucích účinků viz bod 4.8.",4001.0,False
3,4003,CAP,SmPC,cs,1,NÁZEV PŘÍPRAVKU,4001.0,True
4,4004,CAP,SmPC,cs,2,KVALITATIVNÍ A KVANTITATIVNÍ SLOŽENÍ,4001.0,True
5,4005,CAP,SmPC,cs,2.1,Obecný popis,4004.0,False
6,4006,CAP,SmPC,cs,2.2,Kvalitativní a kvantitativní složení,4004.0,False
7,4007,CAP,SmPC,cs,,<Pomocná látka> <Pomocné látky> se známým účinkem,4006.0,False
8,4008,CAP,SmPC,cs,3,LÉKOVÁ FORMA,4001.0,True
9,4009,CAP,SmPC,cs,4,KLINICKÉ ÚDAJE,4001.0,True
10,4010,CAP,SmPC,cs,4.1,Terapeutické indikace,4009.0,True
11,4011,CAP,SmPC,cs,4.2,Dávkování a způsob podání,4009.0,True
12,4012,CAP,SmPC,cs,,Dávkování,4011.0,True
13,4013,CAP,SmPC,cs,,Pediatrická populace,4012.0,True
14,4014,CAP,SmPC,cs,,Způsob podání,4011.0,True
15,4015,CAP,SmPC,cs,,"Opatření, která je nutno učinit před zacházením s léčivým přípravkem nebo před jeho podáním",4014.0,False
16,4016,CAP,SmPC,cs,4.3,Kontraindikace,4009.0,True
17,4017,CAP,SmPC,cs,4.4,Zvláštní upozornění a opatření pro použití,4009.0,True
18,4018,CAP,SmPC,cs,,Sledovatelnost,4017.0,False
19,4019,CAP,SmPC,cs,,Pediatrická populace,4017.0,False
20,4020,CAP,SmPC,cs,4.5,Interakce s jinými léčivými přípravky a jiné formy interakce,4009.0,True
21,4021,CAP,SmPC,cs,,Pediatrická populace,4020.0,False
22,4022,CAP,SmPC,cs,4.6,"Fertilita, těhotenství a kojení",4009.0,True
23,4023,CAP,SmPC,cs,,Těhotenství,4022.0,False
24,4024,CAP,SmPC,cs,,Kojení,4022.0,False
25,4025,CAP,SmPC,cs,,Fertilita,4022.0,False
26,4026,CAP,SmPC,cs,4.7,Účinky na schopnost řídit a obsluhovat stroje,4009.0,True
27,4027,CAP,SmPC,cs,4.8,Nežádoucí účinky,4009.0,True
28,4028,CAP,SmPC,cs,,Pediatrická populace,4027.0,False
29,4029,CAP,SmPC,cs,,Hlášení podezření na nežádoucí účinky,4027.0,True
30,4030,CAP,SmPC,cs,4.9,Předávkování,4009.0,True
31,4031,CAP,SmPC,cs,,Pediatrická populace,4030.0,False
32,4032,CAP,SmPC,cs,5,FARMAKOLOGICKÉ VLASTNOSTI,4001.0,True
33,4033,CAP,SmPC,cs,5.1,Farmakodynamické vlastnosti,4032.0,True
34,4034,CAP,SmPC,cs,,Mechanismus účinku,4033.0,False
35,4035,CAP,SmPC,cs,,Farmakodynamické účinky,4033.0,False
36,4036,CAP,SmPC,cs,,Klinická účinnost a bezpečnost,4033.0,False
37,4037,CAP,SmPC,cs,,Pediatrická populace,4033.0,False
38,4038,CAP,SmPC,cs,5.2,Farmakokinetické vlastnosti,4032.0,True
39,4039,CAP,SmPC,cs,,Absorpce,4038.0,False
40,4040,CAP,SmPC,cs,,Distribuce,4038.0,False
41,4041,CAP,SmPC,cs,,Biotransformace,4038.0,False
42,4042,CAP,SmPC,cs,,Eliminace,4038.0,False
43,4043,CAP,SmPC,cs,,Linearita/nelinearita,4038.0,False
44,4044,CAP,SmPC,cs,,Farmakokinetické/farmakodynamické vztahy,4038.0,False
45,4045,CAP,SmPC,cs,5.3,Předklinické údaje vztahující se k bezpečnosti,4032.0,True
46,4046,CAP,SmPC,cs,,Posouzení rizika pro životní prostředí,4045.0,False
47,4047,CAP,SmPC,cs,6,FARMACEUTICKÉ ÚDAJE,4001.0,True
48,4048,CAP,SmPC,cs,6.1,Seznam pomocných látek,4047.0,True
49,4049,CAP,SmPC,cs,6.2,Inkompatibility,4047.0,True
50,4050,CAP,SmPC,cs,6.3,Doba použitelnosti,4047.0,True
51,4051,CAP,SmPC,cs,6.4,Zvláštní opatření pro uchovávání,4047.0,True
52,4052,CAP,SmPC,cs,6.5,"Druh obalu a obsah balení <a zvláštní vybavení pro použití, podání nebo implantaci>",4047.0,True
53,4053,CAP,SmPC,cs,6.6,Zvláštní opatření pro likvidaci přípravku <a pro zacházení s ním>,4047.0,True
54,4054,CAP,SmPC,cs,,Použití u pediatrické populace,4053.0,False
55,4055,CAP,SmPC,cs,7,DRŽITEL ROZHODNUTÍ O REGISTRACI,4001.0,True
56,4056,CAP,SmPC,cs,8,REGISTRAČNÍ ČÍSLO/REGISTRAČNÍ ČÍSLA ,4001.0,True
57,4057,CAP,SmPC,cs,9,DATUM PRVNÍ REGISTRACE/PRODLOUŽENÍ REGISTRACE,4001.0,True
58,4058,CAP,SmPC,cs,10,DATUM REVIZE TEXTU,4001.0,True
59,4059,CAP,SmPC,cs,11,DOZIMETRIE,4001.0,False
60,4060,CAP,SmPC,cs,12,NÁVOD PRO PŘÍPRAVU RADIOFARMAK,4001.0,False
1,5001,CAP,AnnexII,cs,,PŘÍLOHA II,,True
2,5002,CAP,AnnexII,cs,A,<VÝROBCE/VÝROBCI BIOLOGICKÉ LÉČIVÉ LÁTKY/BIOLOGICKÝCH LÉČIVÝCH LÁTEK A> VÝROBCE ODPOVĚDNÝ/VÝROBCI ODPOVĚDNÍ ZA PROPOUŠTĚNÍ ŠARŽÍ,5001.0,True
3,5003,CAP,AnnexII,cs,,Název a adresa výrobce/výrobců biologické léčivé látky/biologických léčivých látek,5002.0,False
4,5004,CAP,AnnexII,cs,,Název a adresa výrobce odpovědného/výrobců odpovědných za propouštění šarží,5002.0,True
5,5005,CAP,AnnexII,cs,B,PODMÍNKY NEBO OMEZENÍ VÝDEJE A POUŽITÍ ,5001.0,True
6,5006,CAP,AnnexII,cs,,Úřední propouštění šarží,5005.0,False
7,5007,CAP,AnnexII,cs,C,DALŠÍ PODMÍNKY A POŽADAVKY REGISTRACE,5001.0,True
8,5008,CAP,AnnexII,cs,,Pravidelně aktualizované zprávy o bezpečnosti (PSUR),5007.0,True
9,5009,CAP,AnnexII,cs,D,PODMÍNKY NEBO OMEZENÍ S OHLEDEM NA BEZPEČNÉ A ÚČINNÉ POUŽÍVÁNÍ LÉČIVÉHO PŘÍPRAVKU,5001.0,True
10,5010,CAP,AnnexII,cs,,Plán řízení rizik (RMP),5009.0,True
11,5011,CAP,AnnexII,cs,,Další opatření k minimalizaci rizik,5009.0,False
12,5012,CAP,AnnexII,cs,,Povinnost uskutečnit poregistrační opatření,5009.0,False
13,5013,CAP,AnnexII,cs,E,ZVLÁŠTNÍ POVINNOST USKUTEČNIT POREGISTRAČNÍ OPATŘENÍ PRO <PODMÍNĚNOU REGISTRACI PŘÍPRAVKU> <REGISTRACI PŘÍPRAVKU ZA VÝJIMEČNÝCH OKOLNOSTÍ>,5001.0,False
1,6001,CAP,Labelling,cs,,OZNAČENÍ NA OBALU,,True
2,6002,CAP,Labelling,cs,,ÚDAJE UVÁDĚNÉ NA <VNĚJŠÍM OBALU> <A> <VNITŘNÍM OBALU>,6001.0,True
3,6003,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,6002.0,True
4,6004,CAP,Labelling,cs,2,OBSAH LÉČIVÉ LÁTKY/LÉČIVÝCH LÁTEK,6002.0,True
5,6005,CAP,Labelling,cs,3,SEZNAM POMOCNÝCH LÁTEK,6002.0,True
6,6006,CAP,Labelling,cs,4,LÉKOVÁ FORMA A OBSAH BALENÍ,6002.0,True
7,6007,CAP,Labelling,cs,5,ZPŮSOB A CESTA/CESTY PODÁNÍ,6002.0,True
8,6008,CAP,Labelling,cs,6,"ZVLÁŠTNÍ UPOZORNĚNÍ, ŽE LÉČIVÝ PŘÍPRAVEK MUSÍ BÝT UCHOVÁVÁN MIMO DOHLED A DOSAH DĚTÍ",6002.0,True
9,6009,CAP,Labelling,cs,7,"DALŠÍ ZVLÁŠTNÍ UPOZORNĚNÍ, POKUD JE POTŘEBNÉ",6002.0,True
10,6010,CAP,Labelling,cs,8,POUŽITELNOST,6002.0,True
11,6011,CAP,Labelling,cs,9,ZVLÁŠTNÍ PODMÍNKY PRO UCHOVÁVÁNÍ,6002.0,True
12,6012,CAP,Labelling,cs,10,"ZVLÁŠTNÍ OPATŘENÍ PRO LIKVIDACI NEPOUŽITÝCH LÉČIVÝCH PŘÍPRAVKŮ NEBO ODPADU Z NICH, POKUD JE TO VHODNÉ",6002.0,True
13,6013,CAP,Labelling,cs,11,NÁZEV A ADRESA DRŽITELE ROZHODNUTÍ O REGISTRACI,6002.0,True
14,6014,CAP,Labelling,cs,12,REGISTRAČNÍ ČÍSLO/ČÍSLA,6002.0,True
15,6015,CAP,Labelling,cs,13,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU>",6002.0,True
16,6016,CAP,Labelling,cs,14,KLASIFIKACE PRO VÝDEJ,6002.0,True
17,6017,CAP,Labelling,cs,15,NÁVOD K POUŽITÍ,6002.0,True
18,6018,CAP,Labelling,cs,16,INFORMACE V BRAILLOVĚ PÍSMU,6002.0,True
19,6019,CAP,Labelling,cs,17,JEDINEČNÝ IDENTIFIKÁTOR – 2D ČÁROVÝ KÓD,6002.0,True
20,6020,CAP,Labelling,cs,18,JEDINEČNÝ IDENTIFIKÁTOR – DATA ČITELNÁ OKEM,6002.0,True
21,6021,CAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA BLISTRECH NEBO STRIPECH,6001.0,True
22,6022,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU,6021.0,True
23,6023,CAP,Labelling,cs,2,NÁZEV DRŽITELE ROZHODNUTÍ O REGISTRACI,6021.0,True
24,6024,CAP,Labelling,cs,3,POUŽITELNOST,6021.0,True
25,6025,CAP,Labelling,cs,4,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU>",6021.0,True
26,6026,CAP,Labelling,cs,5,JINÉ,6021.0,True
27,6027,CAP,Labelling,cs,,MINIMÁLNÍ ÚDAJE UVÁDĚNÉ NA MALÉM VNITŘNÍM OBALU,6001.0,True
28,6028,CAP,Labelling,cs,1,NÁZEV LÉČIVÉHO PŘÍPRAVKU A CESTA/CESTY PODÁNÍ,6027.0,True
29,6029,CAP,Labelling,cs,2,ZPŮSOB PODÁNÍ,6027.0,True
30,6030,CAP,Labelling,cs,3,POUŽITELNOST,6027.0,True
31,6031,CAP,Labelling,cs,4,"ČÍSLO ŠARŽE <, KÓD DÁRCE A KÓD LÉČIVÉHO PŘÍPRAVKU",6027.0,True
32,6032,CAP,Labelling,cs,5,"OBSAH UDANÝ JAKO HMOTNOST, OBJEM NEBO POČET",6027.0,True
33,6033,CAP,Labelling,cs,6,JINÉ,6027.0,True
1,7001,CAP,Package leaflet,cs,,PŘÍBALOVÁ INFORMACE,,True
2,7002,CAP,Package leaflet,cs,,"qTento přípravek podléhá dalšímu sledování. To umožní rychlé získání nových informací o bezpečnosti. Můžete přispět tím, že nahlásíte jakékoli nežádoucí účinky, které se u Vás vyskytnou. Jak hlásit nežádoucí účinky je popsáno v závěru bodu 4.",7001.0,False
3,7003,CAP,Package leaflet,cs,,Co naleznete v této příbalové informaci,7001.0,True
4,7004,CAP,Package leaflet,cs,1,Co je <přípravek> X a k čemu se používá,7001.0,True
5,7005,CAP,Package leaflet,cs,2,"Čemu musíte věnovat pozornost, než začnete <přípravek> X <užívat> <používat> ",7001.0,True
6,7006,CAP,Package leaflet,cs,,<Neužívejte> <Nepoužívejte> <přípravek> X,7005.0,True
7,7007,CAP,Package leaflet,cs,,Upozornění a opatření ,7005.0,True
8,7008,CAP,Package leaflet,cs,,Děti <a dospívající>,7005.0,True
9,7009,CAP,Package leaflet,cs,,Další léčivé přípravky a <přípravek> X,7005.0,True
10,7010,CAP,Package leaflet,cs,,"<Přípravek> X s <jídlem> <a> <,> <pitím> <a> <alkoholem>",7005.0,True
11,7011,CAP,Package leaflet,cs,,"Těhotenství <a> <,> kojení <a plodnost>",7005.0,True
12,7012,CAP,Package leaflet,cs,,Řízení dopravních prostředků a obsluha strojů,7005.0,True
13,7013,CAP,Package leaflet,cs,,<Přípravek> X obsahuje {název pomocné látky/pomocných látek},7005.0,False
14,7014,CAP,Package leaflet,cs,3,Jak se <přípravek> X <užívá> <používá>,7001.0,True
15,7015,CAP,Package leaflet,cs,,Použití u dětí <a dospívajících>,7014.0,False
16,7016,CAP,Package leaflet,cs,,"Jestliže jste <užil(a)> <použil(a)> více <přípravku>X, než jste měl(a)",7014.0,False
17,7017,CAP,Package leaflet,cs,,Jestliže jste zapomněl(a) <užít> <použít> <přípravek>X,7014.0,False
18,7018,CAP,Package leaflet,cs,,Jestliže jste přestal(a) <užívat> <používat> <přípravek>X,7014.0,False
19,7019,CAP,Package leaflet,cs,4,Možné nežádoucí účinky,7001.0,True
20,7020,CAP,Package leaflet,cs,,Další nežádoucí účinky u dětí <a dospívajících>,7019.0,False
21,7021,CAP,Package leaflet,cs,,Hlášení nežádoucích účinků,7019.0,True
22,7022,CAP,Package leaflet,cs,5,Jak <přípravek> X uchovávat,7001.0,True
23,7023,CAP,Package leaflet,cs,6,Obsah balení a další informace,7001.0,True
24,7024,CAP,Package leaflet,cs,,Co <přípravek> X obsahuje ,7023.0,True
25,7025,CAP,Package leaflet,cs,,Jak<přípravek> X vypadá a co obsahuje toto balení,7023.0,True
26,7026,CAP,Package leaflet,cs,,Držitel rozhodnutí o registraci a výrobce,7023.0,True
27,7027,CAP,Package leaflet,cs,,Další informace o tomto přípravku získáte u místního zástupce držitele rozhodnutí o registraci:,7023.0,False
28,7028,CAP,Package leaflet,cs,,Tato příbalová informace byla naposledy revidována <{DD. MM. RRRR}> <{MM/RRRR}> <{měsíc RRRR}>.,7023.0,True
29,7029,CAP,Package leaflet,cs,,Další zdroje informací,7023.0,False
30,7030,CAP,Package leaflet,cs,,Následující informace jsou určeny pouze pro zdravotnické pracovníky:,7001.0,False
1,8001,CAP,SmPC,de,,SUMMARY OF PRODUCT CHARACTERISTICS,,True
2,8002,CAP,SmPC,de,,"Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Angehörige von Gesundheitsberufen sind aufgefordert, jeden Verdachtsfall einer Nebenwirkung zu melden. Hinweise zur Meldung von Nebenwirkungen, siehe Abschnitt 4.8.",8001.0,False
3,8003,CAP,SmPC,de,1,BEZEICHNUNG DES ARZNEIMITTELS,8001.0,True
4,8004,CAP,SmPC,de,2,QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG,8001.0,True
5,8005,CAP,SmPC,de,2.1,Allgemeine Beschreibung,8004.0,False
6,8006,CAP,SmPC,de,2.2,Qualitative und quantitative Zusammensetzung,8004.0,False
7,8007,CAP,SmPC,de,,Sonstige(r) Bestandteil(e) mit bekannter Wirkung,8006.0,False
8,8008,CAP,SmPC,de,3,DARREICHUNGSFORM,8001.0,True
9,8009,CAP,SmPC,de,4,KLINISCHE ANGABEN,8001.0,True
10,8010,CAP,SmPC,de,4.1,Anwendungsgebiete,8009.0,True
11,8011,CAP,SmPC,de,4.2,Dosierung und Art der Anwendung,8009.0,True
12,8012,CAP,SmPC,de,,Dosierung,8011.0,True
13,8013,CAP,SmPC,de,,Kinder und Jugendliche,8012.0,True
14,8014,CAP,SmPC,de,,Art der Anwendung,8011.0,True
15,8015,CAP,SmPC,de,,Vorsichtsmaßnahmen vor / bei der Handhabung bzw. vor / während der Anwendung des Arzneimittels,8014.0,False
16,8016,CAP,SmPC,de,4.3,Gegenanzeigen,8009.0,True
17,8017,CAP,SmPC,de,4.4,Besondere Warnhinweise und Vorsichtsmaßnahmen für die Anwendung,8009.0,True
18,8018,CAP,SmPC,de,,Rückverfolgbarkeit,8017.0,False
19,8019,CAP,SmPC,de,,Kinder und Jugendliche,8017.0,False
20,8020,CAP,SmPC,de,4.5,Wechselwirkungen mit anderen Arzneimitteln und sonstige Wechselwirkungen,8009.0,True
21,8021,CAP,SmPC,de,,Kinder und Jugendliche,8020.0,False
22,8022,CAP,SmPC,de,4.6,"Fertilität, Schwangerschaft und Stillzeit",8009.0,True
23,8023,CAP,SmPC,de,,Schwangerschaft,8022.0,False
24,8024,CAP,SmPC,de,,Stillzeit,8022.0,False
25,8025,CAP,SmPC,de,,Fertilität,8022.0,False
26,8026,CAP,SmPC,de,4.7,Auswirkungen auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen,8009.0,True
27,8027,CAP,SmPC,de,4.8,Nebenwirkungen,8009.0,True
28,8028,CAP,SmPC,de,,Kinder und Jugendliche,8027.0,False
29,8029,CAP,SmPC,de,,Meldung des Verdachts auf Nebenwirkungen,8027.0,True
30,8030,CAP,SmPC,de,4.9,Überdosierung,8009.0,True
31,8031,CAP,SmPC,de,,Kinder und Jugendliche,8030.0,False
32,8032,CAP,SmPC,de,5,PHARMAKOLOGISCHE EIGENSCHAFTEN,8001.0,True
33,8033,CAP,SmPC,de,5.1,Pharmakodynamische Eigenschaften,8032.0,True
34,8034,CAP,SmPC,de,,Wirkmechanismus,8033.0,False
35,8035,CAP,SmPC,de,,Pharmakodynamische Wirkungen,8033.0,False
36,8036,CAP,SmPC,de,,Klinische Wirksamkeit und Sicherheit,8033.0,False
37,8037,CAP,SmPC,de,,Kinder und Jugendliche,8033.0,False
38,8038,CAP,SmPC,de,5.2,Pharmakokinetische Eigenschaften,8032.0,True
39,8039,CAP,SmPC,de,,Resorption,8038.0,False
40,8040,CAP,SmPC,de,,Verteilung,8038.0,False
41,8041,CAP,SmPC,de,,Biotransformation,8038.0,False
42,8042,CAP,SmPC,de,,Elimination,8038.0,False
43,8043,CAP,SmPC,de,,Linearität/Nicht-Linearität,8038.0,False
44,8044,CAP,SmPC,de,,Pharmakokinetische/pharmakodynamische Zusammenhänge,8038.0,False
45,8045,CAP,SmPC,de,5.3,Präklinische Daten zur Sicherheit,8032.0,True
46,8046,CAP,SmPC,de,,Beurteilung der Risiken für die Umwelt (Environmental risk assessment [ERA]),8045.0,False
47,8047,CAP,SmPC,de,6,PHARMAZEUTISCHE ANGABEN,8001.0,True
48,8048,CAP,SmPC,de,6.1,Liste der sonstigen Bestandteile,8047.0,True
49,8049,CAP,SmPC,de,6.2,Inkompatibilitäten,8047.0,True
50,8050,CAP,SmPC,de,6.3,Dauer der Haltbarkeit,8047.0,True
51,8051,CAP,SmPC,de,6.4,Besondere Vorsichtsmaßnahmen für die Aufbewahrung,8047.0,True
52,8052,CAP,SmPC,de,6.5,"Art und Inhalt des Behältnisses <und spezielles Zubehör für den Gebrauch, die Anwendung oder die Implantation>",8047.0,True
53,8053,CAP,SmPC,de,6.6,Besondere Vorsichtsmaßnahmen für die Beseitigung <und sonstige Hinweise zur Handhabung>,8047.0,True
54,8054,CAP,SmPC,de,,Anwendung bei Kindern und Jugendlichen,8053.0,False
55,8055,CAP,SmPC,de,7,INHABER DER ZULASSUNG,8001.0,True
56,8056,CAP,SmPC,de,8,ZULASSUNGSNUMMER(N),8001.0,True
57,8057,CAP,SmPC,de,9,DATUM DER ERTEILUNG DER ZULASSUNG/VERLÄNGERUNG DER ZULASSUNG,8001.0,True
58,8058,CAP,SmPC,de,10,STAND DER INFORMATION,8001.0,True
59,8059,CAP,SmPC,de,11,DOSIMETRIE,8001.0,False
60,8060,CAP,SmPC,de,12,ANWEISUNGEN ZUR ZUBEREITUNG VON RADIOAKTIVEN ARZNEIMITTELN,8001.0,False
1,9001,CAP,ANHANG II,de,,ANHANG II,,True
2,9002,CAP,ANHANG II,de,A,"<HERSTELLER DES WIRKSTOFFS/DER WIRKSTOFFE BIOLOGISCHEN URSPRUNGS UND> HERSTELLER, DER (DIE) FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST (SIND)",9001.0,True
3,9003,CAP,ANHANG II,de,,Name und Anschrift des (der) Hersteller(s) des Wirkstoffs/der Wirkstoffe biologischen Ursprungs,9002.0,False
4,9004,CAP,ANHANG II,de,,"Name und Anschrift des (der) Hersteller(s), der (die) für die Chargenfreigabe verantwortlich ist (sind)",9002.0,True
5,9005,CAP,ANHANG II,de,B,BEDINGUNGEN ODER EINSCHRÄNKUNGEN FÜR DIE ABGABE UND DEN GEBRAUCH ,9001.0,True
6,9006,CAP,ANHANG II,de,,Amtliche Chargenfreigabe,9005.0,False
7,9007,CAP,ANHANG II,de,C,SONSTIGE BEDINGUNGEN UND AUFLAGEN DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN,9001.0,True
8,9008,CAP,ANHANG II,de,,Regelmäßig aktualisierte Unbedenklichkeitsberichte [Periodic Safety Update Reports (PSURs)],9007.0,True
9,9009,CAP,ANHANG II,de,D,BEDINGUNGEN ODER EINSCHRÄNKUNGEN FÜR DIE SICHERE UND WIRKSAME ANWENDUNG DES ARZNEIMITTELS,9001.0,True
10,9010,CAP,ANHANG II,de,,Risikomanagement-Plan (RMP),9009.0,True
11,9011,CAP,ANHANG II,de,,Zusätzliche Maßnahmen zur Risikominimierung,9009.0,False
12,9012,CAP,ANHANG II,de,,Verpflichtung zur Durchführung von Maßnahmen nach der Zulassung ,9009.0,False
13,9013,CAP,ANHANG II,de,E,SPEZIFISCHE VERPFLICHTUNG ZUM ABSCHLUSS VON MASSNAHMEN NACH DER ZULASSUNG <UNTER „BESONDEREN BEDINGUNGEN“> <UNTER „AUSSERGEWÖHNLICHEN UMSTÄNDEN“,9001.0,False
1,10001,CAP,Etikettierung,de,,ETIKETTIERUNG ,,True
2,10002,CAP,Etikettierung,de,,ANGABEN <AUF DER ÄUSSEREN UMHÜLLUNG> <UND> <AUF DEM BEHÄLTNIS>,10001.0,True
3,10003,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,10002.0,True
4,10004,CAP,Etikettierung,de,2,WIRKSTOFF(E),10002.0,True
5,10005,CAP,Etikettierung,de,3,SONSTIGE BESTANDTEILE,10002.0,True
6,10006,CAP,Etikettierung,de,4,DARREICHUNGSFORM UND INHALT,10002.0,True
7,10007,CAP,Etikettierung,de,5,HINWEISE ZUR UND ART(EN) DER ANWENDUNG,10002.0,True
8,10008,CAP,Etikettierung,de,6,"WARNHINWEIS, DASS DAS ARZNEIMITTEL FÜR KINDER UNZUGÄNGLICH AUFZUBEWAHREN IST",10002.0,True
9,10009,CAP,Etikettierung,de,7,"WEITERE WARNHINWEISE, FALLS ERFORDERLICH",10002.0,True
10,10010,CAP,Etikettierung,de,8,VERFALLDATUM,10002.0,True
11,10011,CAP,Etikettierung,de,9,BESONDERE VORSICHTSMASSNAHMEN FÜR DIE AUFBEWAHRUNG,10002.0,True
12,10012,CAP,Etikettierung,de,10,GEGEBENENFALLS BESONDERE VORSICHTSMASSNAHMEN FÜR DIE BESEITIGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER DAVON STAMMENDEN ABFALLMATERIALIEN,10002.0,True
13,10013,CAP,Etikettierung,de,11,NAME UND ANSCHRIFT DES PHARMAZEUTISCHEN UNTERNEHMERS,10002.0,True
14,10014,CAP,Etikettierung,de,12,ZULASSUNGSNUMMER(N) ,10002.0,True
15,10015,CAP,Etikettierung,de,13,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",10002.0,True
16,10016,CAP,Etikettierung,de,14,VERKAUFSABGRENZUNG,10002.0,True
17,10017,CAP,Etikettierung,de,15,HINWEISE FÜR DEN GEBRAUCH,10002.0,True
18,10018,CAP,Etikettierung,de,16,ANGABEN IN BLINDENSCHRIFT,10002.0,True
19,10019,CAP,Etikettierung,de,17,INDIVIDUELLES ERKENNUNGSMERKMAL – 2D-BARCODE,10002.0,True
20,10020,CAP,Etikettierung,de,18,INDIVIDUELLES ERKENNUNGSMERKMAL – VOM MENSCHEN LESBARES FORMAT,10002.0,True
21,10021,CAP,Etikettierung,de,,MINDESTANGABEN AUF BLISTERPACKUNGEN ODER FOLIENSTREIFEN,10001.0,True
22,10022,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS,10021.0,True
23,10023,CAP,Etikettierung,de,2,NAME DES PHARMAZEUTISCHEN UNTERNEHMERS,10021.0,True
24,10024,CAP,Etikettierung,de,3,VERFALLDATUM,10021.0,True
25,10025,CAP,Etikettierung,de,4,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",10021.0,True
26,10026,CAP,Etikettierung,de,5,WEITERE ANGABEN,10021.0,True
27,10027,CAP,Etikettierung,de,,MINDESTANGABEN AUF KLEINEN BEHÄLTNISSEN,10001.0,True
28,10028,CAP,Etikettierung,de,1,BEZEICHNUNG DES ARZNEIMITTELS SOWIE ART(EN) DER ANWENDUNG,10027.0,True
29,10029,CAP,Etikettierung,de,2,HINWEISE ZUR ANWENDUNG,10027.0,True
30,10030,CAP,Etikettierung,de,3,VERFALLDATUM,10027.0,True
31,10031,CAP,Etikettierung,de,4,"CHARGENBEZEICHNUNG<, SPENDER- UND PRODUKTCODE>",10027.0,True
32,10032,CAP,Etikettierung,de,5,"INHALT NACH GEWICHT, VOLUMEN ODER EINHEITEN",10027.0,True
33,10033,CAP,Etikettierung,de,6,WEITERE ANGABEN,10027.0,True
1,11001,CAP,Packungsbeilage,de,,PACKUNGSBEILAGE,,True
2,11002,CAP,Packungsbeilage,de,,"q Dieses Arzneimittel unterliegt einer zusätzlichen Überwachung. Dies ermöglicht eine schnelle Identifizierung neuer Erkenntnisse über die Sicherheit. Sie können dabei helfen, indem Sie jede auftretende Nebenwirkung melden. Hinweise zur Meldung von Nebenwirkungen, siehe Ende Abschnitt 4",11001.0,False
3,11003,CAP,Packungsbeilage,de,,Was in dieser Packungsbeilage steht,11001.0,True
4,11004,CAP,Packungsbeilage,de,1,Was ist X und wofür wird es angewendet?,11001.0,True
5,11005,CAP,Packungsbeilage,de,2,Was sollten Sie vor der <Einnahme> <Anwendung> von X beachten?,11001.0,True
6,11006,CAP,Packungsbeilage,de,,"X darf nicht <eingenommen> <angewendet> werden<,>",11005.0,True
7,11007,CAP,Packungsbeilage,de,,Warnhinweise und Vorsichtsmaßnahmen,11005.0,True
8,11008,CAP,Packungsbeilage,de,,Kinder <und Jugendliche>,11005.0,True
9,11009,CAP,Packungsbeilage,de,,<Einnahme> <Anwendung> von X zusammen mit anderen Arzneimitteln,11005.0,True
10,11010,CAP,Packungsbeilage,de,,"<Einnahme> <Anwendung> von X zusammen mit <Nahrungsmitteln> <und> <,> <Getränken> <und> <Alkohol>",11005.0,True
11,11011,CAP,Packungsbeilage,de,,"Schwangerschaft <und> <,> Stillzeit <und Fortpflanzungsfähigkeit>",11005.0,True
12,11012,CAP,Packungsbeilage,de,,Verkehrstüchtigkeit und Fähigkeit zum Bedienen von Maschinen,11005.0,True
13,11013,CAP,Packungsbeilage,de,,X enthält {Bezeichnung <des> <der> sonstigen Bestandteil(s)(e)},11005.0,False
14,11014,CAP,Packungsbeilage,de,3,Wie ist X <einzunehmen> <anzuwenden>?,11001.0,True
15,11015,CAP,Packungsbeilage,de,,Anwendung bei Kindern <und Jugendlichen>,11014.0,False
16,11016,CAP,Packungsbeilage,de,,"Wenn Sie eine größere Menge von X <eingenommen> <angewendet> haben, als Sie sollten",11014.0,False
17,11017,CAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X vergessen haben,11014.0,False
18,11018,CAP,Packungsbeilage,de,,Wenn Sie die <Einnahme> <Anwendung> von X abbrechen,11014.0,False
19,11019,CAP,Packungsbeilage,de,4,Welche Nebenwirkungen sind möglich?,11001.0,True
20,11020,CAP,Packungsbeilage,de,,Zusätzliche Nebenwirkungen bei Kindern <und Jugendlichen>,11019.0,False
21,11021,CAP,Packungsbeilage,de,,Meldung von Nebenwirkungen,11019.0,True
22,11022,CAP,Packungsbeilage,de,5,Wie ist X aufzubewahren?,11001.0,True
23,11023,CAP,Packungsbeilage,de,6,Inhalt der Packung und weitere Informationen,11001.0,True
24,11024,CAP,Packungsbeilage,de,,Was X enthält,11023.0,True
25,11025,CAP,Packungsbeilage,de,,Wie X aussieht und Inhalt der Packung,11023.0,True
26,11026,CAP,Packungsbeilage,de,,Pharmazeutischer Unternehmer und Hersteller,11023.0,True
27,11027,CAP,Packungsbeilage,de,,"Falls Sie weitere Informationen über das Arzneimittel wünschen, setzen Sie sich bitte mit dem örtlichen Vertreter des pharmazeutischen Unternehmers in Verbindung:",11023.0,False
28,11028,CAP,Packungsbeilage,de,,Diese Packungsbeilage wurde zuletzt überarbeitet im <{MM.JJJJ}> <{Monat JJJJ}>.,11023.0,True
29,11029,CAP,Packungsbeilage,de,,Weitere Informationsquellen,11023.0,False
30,11030,CAP,Packungsbeilage,de,,Die folgenden Informationen sind für medizinisches Fachpersonal bestimmt:,11001.0,False
1,12001,CAP,SmPC,es,,FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS DEL PRODUCTO,,True
2,12002,CAP,SmPC,es,,"qEste medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Se invita a los profesionales sanitarios a notificar las sospechas de reacciones adversas. Ver  la sección 4.8, en la que se incluye información sobre cómo notificarlas.",12001.0,False
3,12003,CAP,SmPC,es,1,NOMBRE DEL MEDICAMENTO,12001.0,True
4,12004,CAP,SmPC,es,2,COMPOSICIÓN CUALITATIVA Y CUANTITATIVA,12001.0,True
5,12005,CAP,SmPC,es,2.1,Descripción general,12004.0,False
6,12006,CAP,SmPC,es,2.2,Composición cualitativa y cuantitativa,12004.0,False
7,12007,CAP,SmPC,es,,Excipiente(s) con efecto conocido,12006.0,False
8,12008,CAP,SmPC,es,3,FORMA FARMACÉUTICA,12001.0,True
9,12009,CAP,SmPC,es,4,DATOS CLÍNICOS,12001.0,True
10,12010,CAP,SmPC,es,4.1,Indicaciones terapéuticas,12009.0,True
11,12011,CAP,SmPC,es,4.2,Posología y forma de administración,12009.0,True
12,12012,CAP,SmPC,es,,Posología,12011.0,True
13,12013,CAP,SmPC,es,,Población pediátrica,12012.0,True
14,12014,CAP,SmPC,es,,Forma de administración ,12011.0,True
15,12015,CAP,SmPC,es,,Precauciones que se deben tomar antes de manipular o administrar el medicamento,12014.0,False
16,12016,CAP,SmPC,es,4.3,Contraindicaciones,12009.0,True
17,12017,CAP,SmPC,es,4.4,Advertencias y precauciones especiales de empleo,12009.0,True
18,12018,CAP,SmPC,es,,Trazabilidad,12017.0,False
19,12019,CAP,SmPC,es,,Población pediátrica,12017.0,False
20,12020,CAP,SmPC,es,4.5,Interacción con otros medicamentos y otras formas de interacción,12009.0,True
21,12021,CAP,SmPC,es,,Población pediátrica,12020.0,False
22,12022,CAP,SmPC,es,4.6,"Fertilidad, embarazo y lactancia",12009.0,True
23,12023,CAP,SmPC,es,,Embarazo,12022.0,False
24,12024,CAP,SmPC,es,,Lactancia,12022.0,False
25,12025,CAP,SmPC,es,,Fertilidad,12022.0,False
26,12026,CAP,SmPC,es,4.7,Efectos sobre la capacidad para conducir y utilizar máquinas,12009.0,True
27,12027,CAP,SmPC,es,4.8,Reacciones adversas,12009.0,True
28,12028,CAP,SmPC,es,,Población pediátrica,12027.0,False
29,12029,CAP,SmPC,es,,Notificación de sospechas de reacciones adversas,12027.0,True
30,12030,CAP,SmPC,es,4.9,Sobredosis,12009.0,True
31,12031,CAP,SmPC,es,,Población pediátrica,12030.0,False
32,12032,CAP,SmPC,es,5,PROPIEDADES FARMACOLÓGICAS,12001.0,True
33,12033,CAP,SmPC,es,5.1,Propiedades farmacodinámicas,12032.0,True
34,12034,CAP,SmPC,es,,Mecanismo de acción,12033.0,False
35,12035,CAP,SmPC,es,,Efectos farmacodinámicos,12033.0,False
36,12036,CAP,SmPC,es,,Eficacia clínica y seguridad,12033.0,False
37,12037,CAP,SmPC,es,,Población pediátrica,12033.0,False
38,12038,CAP,SmPC,es,5.2,Propiedades farmacocinéticas,12032.0,True
39,12039,CAP,SmPC,es,,Absorción,12038.0,False
40,12040,CAP,SmPC,es,,Distribución,12038.0,False
41,12041,CAP,SmPC,es,,Biotransformación,12038.0,False
42,12042,CAP,SmPC,es,,Eliminación,12038.0,False
43,12043,CAP,SmPC,es,,Linealidad/No linealidad,12038.0,False
44,12044,CAP,SmPC,es,,Relación(es) farmacocinéticas/farmacodinámica(s),12038.0,False
45,12045,CAP,SmPC,es,5.3,Datos preclínicos sobre seguridad,12032.0,True
46,12046,CAP,SmPC,es,,"Evaluación del riesgo medioambiental (ERA, por sus siglas en inglés)",12045.0,False
47,12047,CAP,SmPC,es,6,DATOS FARMACÉUTICOS,12001.0,True
48,12048,CAP,SmPC,es,6.1,Lista de excipientes,12047.0,True
49,12049,CAP,SmPC,es,6.2,Incompatibilidades,12047.0,True
50,12050,CAP,SmPC,es,6.3,Periodo de validez,12047.0,True
51,12051,CAP,SmPC,es,6.4,Precauciones especiales de conservación,12047.0,True
52,12052,CAP,SmPC,es,6.5,"Naturaleza y contenido del envase <y de los equipos especiales para su utilización, administración o implantación>",12047.0,True
53,12053,CAP,SmPC,es,6.6,Precauciones especiales de eliminación <y otras manipulaciones>,12047.0,True
54,12054,CAP,SmPC,es,,Uso en la población pediátrica ,12053.0,False
55,12055,CAP,SmPC,es,7,TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,12001.0,True
56,12056,CAP,SmPC,es,8,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,12001.0,True
57,12057,CAP,SmPC,es,9,FECHA DE LA PRIMERA AUTORIZACIÓN/RENOVACIÓN DE LA AUTORIZACIÓN,12001.0,True
58,12058,CAP,SmPC,es,10,FECHA DE LA REVISIÓN DEL TEXTO,12001.0,True
59,12059,CAP,SmPC,es,11,DOSIMETRÍA,12001.0,False
60,12060,CAP,SmPC,es,12,INSTRUCCIONES PARA LA PREPARACIÓN DE RADIOFÁRMACOS,12001.0,False
1,13001,CAP,AnnexII,es,,ANEXO II,,True
2,13002,CAP,AnnexII,es,A,<FABRICANTE(S) DEL (DE LOS) PRINCIPIO(S) ACTIVO(S) BIOLÓGICO(S) Y> FABRICANTE(S) RESPONSABLE(S) DE LA LIBERACIÓN DE LOS LOTES,13001.0,True
3,13003,CAP,AnnexII,es,,Nombre y dirección del (de los) fabricante(s) del (de los) principio(s) activo(s) biológico(s).,13002.0,False
4,13004,CAP,AnnexII,es,,Nombre y dirección del (de los) fabricante(s) responsable(s) de la liberación de los lotes,13002.0,True
5,13005,CAP,AnnexII,es,B,CONDICIONES O RESTRICCIONES DE SUMINISTRO Y USO ,13001.0,True
6,13006,CAP,AnnexII,es,,Liberación oficial de los lotes,13005.0,False
7,13007,CAP,AnnexII,es,C,OTRAS CONDICIONES Y REQUISITOS DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,13001.0,True
8,13008,CAP,AnnexII,es,,Informes periódicos de seguridad (IPSs),13007.0,True
9,13009,CAP,AnnexII,es,D,CONDICIONES O RESTRICCIONES EN RELACIÓN CON LA UTILIZACIÓN SEGURA Y EFICAZ DEL MEDICAMENTO  ,13001.0,True
10,13010,CAP,AnnexII,es,,Plan de gestión de riesgos (PGR),13009.0,True
11,13011,CAP,AnnexII,es,,Medidas adicionales de minimización de riesgos,13009.0,False
12,13012,CAP,AnnexII,es,,Obligación de llevar a cabo medidas posautorización,13009.0,False
13,13013,CAP,AnnexII,es,E,OBLIGACIÓN ESPECÍFICA DE LLEVAR A CABO MEDIDAS POSAUTORIZACIÓN EN RELACIÓN <CON UNA AUTORIZACIÓN DE COMERCIALIZACIÓN CONDICIONAL><CON UNA AUTORIZACIÓN DE COMERCIALIZACIÓN EN CIRCUNSTANCIAS EXCEPCIONALES,13001.0,False
1,14001,CAP,Labelling,es,,ETIQUETADO,,True
2,14002,CAP,Labelling,es,,INFORMACIÓN QUE DEBE FIGURAR EN <EL EMBALAJE EXTERIOR><Y><EL ACONDICIONAMIENTO PRIMARIO>,14001.0,True
3,14003,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,14002.0,True
4,14004,CAP,Labelling,es,2,PRINCIPIO(S) ACTIVO(S),14002.0,True
5,14005,CAP,Labelling,es,3,LISTA DE EXCIPIENTES,14002.0,True
6,14006,CAP,Labelling,es,4,FORMA FARMACÉUTICA Y CONTENIDO DEL ENVASE,14002.0,True
7,14007,CAP,Labelling,es,5,FORMA Y VÍA(S) DE ADMINISTRACIÓN,14002.0,True
8,14008,CAP,Labelling,es,6,ADVERTENCIA ESPECIAL DE QUE EL MEDICAMENTO DEBE MANTENERSE FUERA DE LA VISTA Y DEL ALCANCE DE LOS NIÑOS,14002.0,True
9,14009,CAP,Labelling,es,7,"OTRA(S) ADVERTENCIA(S) ESPECIAL(ES), SI ES NECESARIO",14002.0,True
10,14010,CAP,Labelling,es,8,FECHA DE CADUCIDAD,14002.0,True
11,14011,CAP,Labelling,es,9,CONDICIONES ESPECIALES DE CONSERVACIÓN,14002.0,True
12,14012,CAP,Labelling,es,10,"PRECAUCIONES ESPECIALES DE ELIMINACIÓN DEL MEDICAMENTO NO UTILIZADO Y DE LOS MATERIALES DERIVADOS DE SU USO, CUANDO CORRESPONDA",14002.0,True
13,14013,CAP,Labelling,es,11,NOMBRE Y DIRECCIÓN DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,14002.0,True
14,14014,CAP,Labelling,es,12,NÚMERO(S) DE AUTORIZACIÓN DE COMERCIALIZACIÓN ,14002.0,True
15,14015,CAP,Labelling,es,13,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",14002.0,True
16,14016,CAP,Labelling,es,14,CONDICIONES GENERALES DE DISPENSACIÓN,14002.0,True
17,14017,CAP,Labelling,es,15,INSTRUCCIONES DE USO,14002.0,True
18,14018,CAP,Labelling,es,16,INFORMACIÓN EN BRAILLE,14002.0,True
19,14019,CAP,Labelling,es,17,IDENTIFICADOR ÚNICO - CÓDIGO DE BARRAS 2D,14002.0,True
20,14020,CAP,Labelling,es,18,IDENTIFICADOR ÚNICO - INFORMACIÓN EN CARACTERES VISUALES,14002.0,True
21,14021,CAP,Labelling,es,,INFORMACIÓN MÍNIMA A INCLUIR EN BLÍSTERES O TIRAS,14001.0,True
22,14022,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO,14021.0,True
23,14023,CAP,Labelling,es,2,NOMBRE DEL TITULAR DE LA AUTORIZACIÓN DE COMERCIALIZACIÓN,14021.0,True
24,14024,CAP,Labelling,es,3,FECHA DE CADUCIDAD,14021.0,True
25,14025,CAP,Labelling,es,4,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",14021.0,True
26,14026,CAP,Labelling,es,5,OTROS,14021.0,True
27,14027,CAP,Labelling,es,,INFORMACIÓN MÍNIMA QUE DEBE INCLUIRSE EN PEQUEÑOS ACONDICIONAMIENTOS PRIMARIOS,14001.0,True
28,14028,CAP,Labelling,es,1,NOMBRE DEL MEDICAMENTO Y VÍA(S) DE ADMINISTRACIÓN,14027.0,True
29,14029,CAP,Labelling,es,2,FORMA DE ADMINISTRACIÓN,14027.0,True
30,14030,CAP,Labelling,es,3,FECHA DE CADUCIDAD,14027.0,True
31,14031,CAP,Labelling,es,4,"NÚMERO DE LOTE <, CÓDIGO DE DONACIÓN Y DEL PRODUCTO >",14027.0,True
32,14032,CAP,Labelling,es,5,"CONTENIDO EN PESO, EN VOLUMEN O EN UNIDADES",14027.0,True
33,14033,CAP,Labelling,es,6,OTROS,14027.0,True
1,15001,CAP,Package leaflet,es,,PROSPECTO,,True
2,15002,CAP,Package leaflet,es,,"q Este medicamento está sujeto a seguimiento adicional, lo que agilizará la detección de nueva información sobre su seguridad. Puede contribuir comunicando los efectos adversos que pudiera usted tener. La parte final de la sección 4 incluye información sobre cómo comunicar estos efectos adversos.",15001.0,False
3,15003,CAP,Package leaflet,es,,Contenido del prospecto,15001.0,True
4,15004,CAP,Package leaflet,es,1,Qué es X y para qué se utiliza,15001.0,True
5,15005,CAP,Package leaflet,es,2,Qué necesita saber antes de empezar a <tomar><usar> X,15001.0,True
6,15006,CAP,Package leaflet,es,,No <tome><use> X,15005.0,True
7,15007,CAP,Package leaflet,es,,Advertencias y precauciones ,15005.0,True
8,15008,CAP,Package leaflet,es,,Niños <y adolescentes>,15005.0,True
9,15009,CAP,Package leaflet,es,,Otros medicamentos y X,15005.0,True
10,15010,CAP,Package leaflet,es,,"<Uso><Toma> de X con <alimentos><y><,><bebidas><y><alcohol>",15005.0,True
11,15011,CAP,Package leaflet,es,,"Embarazo <y><,> lactancia <y fertilidad>",15005.0,True
12,15012,CAP,Package leaflet,es,,Conducción y uso de máquinas,15005.0,True
13,15013,CAP,Package leaflet,es,,X contiene {nombre del (de los) excipiente(s)},15005.0,False
14,15014,CAP,Package leaflet,es,3,Cómo <tomar><usar> X,15001.0,True
15,15015,CAP,Package leaflet,es,,Uso en niños <y adolescentes>,15014.0,False
16,15016,CAP,Package leaflet,es,,Si <toma><usa> más X del que debe,15014.0,False
17,15017,CAP,Package leaflet,es,,Si olvidó <tomar><usar> X,15014.0,False
18,15018,CAP,Package leaflet,es,,Si interrumpe el tratamiento con X,15014.0,False
19,15019,CAP,Package leaflet,es,4,Posibles efectos adversos,15001.0,True
20,15020,CAP,Package leaflet,es,,Otros efectos adversos en niños <y adolescentes>,15019.0,False
21,15021,CAP,Package leaflet,es,,Comunicación de efectos adversos,15019.0,True
22,15022,CAP,Package leaflet,es,5,Conservación de X,15001.0,True
23,15023,CAP,Package leaflet,es,6,Contenido del envase e información adicional,15001.0,True
24,15024,CAP,Package leaflet,es,,Composición de X ,15023.0,True
25,15025,CAP,Package leaflet,es,,Aspecto del producto y contenido del envase,15023.0,True
26,15026,CAP,Package leaflet,es,,Titular de la autorización de comercialización y responsable de la fabricación,15023.0,True
27,15027,CAP,Package leaflet,es,,Pueden solicitar más información respecto a este medicamento dirigiéndose al representante local del titular de la autorización de comercialización:,15023.0,False
28,15028,CAP,Package leaflet,es,,Fecha de la última revisión de este prospecto: <{MM/AAAA}><{mes AAAA}>.,15023.0,True
29,15029,CAP,Package leaflet,es,,Otras fuentes de información,15023.0,False
30,15030,CAP,Package leaflet,es,,Esta información está destinada únicamente a profesionales sanitarios:,15001.0,False
1,16001,CAP,SmPC,et,,RAVIMI OMADUSTE KOKKUVÕTE,,True
2,16002,CAP,SmPC,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Tervishoiutöötajatel palutakse teatada kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.8.>",16001.0,False
3,16003,CAP,SmPC,et,1,RAVIMPREPARAADI NIMETUS,16001.0,True
4,16004,CAP,SmPC,et,2,KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS,16001.0,True
5,16005,CAP,SmPC,et,2.1,Üldkirjeldus,16004.0,False
6,16006,CAP,SmPC,et,2.2,Kvalitatiivne ja kvantitatiivne koostis,16004.0,False
7,16007,CAP,SmPC,et,,Teadaolevat toimet omav(ad) abiaine(d),16006.0,False
8,16008,CAP,SmPC,et,3,RAVIMVORM,16001.0,True
9,16009,CAP,SmPC,et,4,KLIINILISED ANDMED,16001.0,True
10,16010,CAP,SmPC,et,4.1,Näidustused,16009.0,True
11,16011,CAP,SmPC,et,4.2,Annustamine ja manustamisviis,16009.0,True
12,16012,CAP,SmPC,et,,Annustamine,16011.0,True
13,16013,CAP,SmPC,et,,Lapsed,16012.0,True
14,16014,CAP,SmPC,et,,Manustamisviis,16011.0,True
15,16015,CAP,SmPC,et,,Enne ravimi käsitsemist või manustamist tuleb järgida ettevaatusabinõusid,16014.0,False
16,16016,CAP,SmPC,et,4.3,Vastunäidustused,16009.0,True
17,16017,CAP,SmPC,et,4.4,Erihoiatused ja ettevaatusabinõud kasutamisel,16009.0,True
18,16018,CAP,SmPC,et,,Jälgitavus,16017.0,False
19,16019,CAP,SmPC,et,,Lapsed,16017.0,False
20,16020,CAP,SmPC,et,4.5,Koostoimed teiste ravimitega ja muud koostoimed,16009.0,True
21,16021,CAP,SmPC,et,,Lapsed,16020.0,False
22,16022,CAP,SmPC,et,4.6,"Fertiilsus, rasedus ja imetamine",16009.0,True
23,16023,CAP,SmPC,et,,Rasedus,16022.0,False
24,16024,CAP,SmPC,et,,Imetamine,16022.0,False
25,16025,CAP,SmPC,et,,Fertiilsus,16022.0,False
26,16026,CAP,SmPC,et,4.7,Toime reaktsioonikiirusele,16009.0,True
27,16027,CAP,SmPC,et,4.8,Kõrvaltoimed,16009.0,True
28,16028,CAP,SmPC,et,,Lapsed,16027.0,False
29,16029,CAP,SmPC,et,,Võimalikest kõrvaltoimetest teatamine,16027.0,True
30,16030,CAP,SmPC,et,4.9,Üleannustamine,16009.0,True
31,16031,CAP,SmPC,et,,Lapsed,16030.0,False
32,16032,CAP,SmPC,et,5,FARMAKOLOOGILISED OMADUSED,16001.0,True
33,16033,CAP,SmPC,et,5.1,Farmakodünaamilised omadused,16032.0,True
34,16034,CAP,SmPC,et,,Toimemehhanism,16033.0,False
35,16035,CAP,SmPC,et,,Farmakodünaamilised toimed,16033.0,False
36,16036,CAP,SmPC,et,,Kliiniline efektiivsus ja ohutus,16033.0,False
37,16037,CAP,SmPC,et,,Lapsed,16033.0,False
38,16038,CAP,SmPC,et,5.2,Farmakokineetilised omadused,16032.0,True
39,16039,CAP,SmPC,et,,Imendumine,16038.0,False
40,16040,CAP,SmPC,et,,Jaotumine,16038.0,False
41,16041,CAP,SmPC,et,,Biotransformatsioon,16038.0,False
42,16042,CAP,SmPC,et,,Eritumine,16038.0,False
43,16043,CAP,SmPC,et,,Lineaarsus/mittelineaarsus,16038.0,False
44,16044,CAP,SmPC,et,,Farmakokineetilised/farmakodünaamilised toimed,16038.0,False
45,16045,CAP,SmPC,et,5.3,Prekliinilised ohutusandmed,16032.0,True
46,16046,CAP,SmPC,et,,Keskkonnariski hindamine,16045.0,False
47,16047,CAP,SmPC,et,6,FARMATSEUTILISED ANDMED,16001.0,True
48,16048,CAP,SmPC,et,6.1,Abiainete loetelu,16047.0,True
49,16049,CAP,SmPC,et,6.2,Sobimatus,16047.0,True
50,16050,CAP,SmPC,et,6.3,Kõlblikkusaeg,16047.0,True
51,16051,CAP,SmPC,et,6.4,Säilitamise eritingimused,16047.0,True
52,16052,CAP,SmPC,et,6.5,"Pakendi iseloomustus ja sisu <ja kasutamise, manustamise või implanteerimise erivahendid>",16047.0,True
53,16053,CAP,SmPC,et,6.6,Erihoiatused ravimpreparaadi hävitamiseks <ja käsitlemiseks>,16047.0,True
54,16054,CAP,SmPC,et,,Kasutamine lastel,16053.0,False
55,16055,CAP,SmPC,et,7,MÜÜGILOA HOIDJA,16001.0,True
56,16056,CAP,SmPC,et,8,MÜÜGILOA NUMBER (NUMBRID) ,16001.0,True
57,16057,CAP,SmPC,et,9,ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV,16001.0,True
58,16058,CAP,SmPC,et,10,TEKSTI LÄBIVAATAMISE KUUPÄEV,16001.0,True
59,16059,CAP,SmPC,et,11,DOSIMEETRIA,16001.0,False
60,16060,CAP,SmPC,et,12,RADIOFARMATSEUTILISE PREPARAADI VALMISTAMISE JUHEND,16001.0,False
1,17001,CAP,AnnexII,et,,II LISA,,True
2,17002,CAP,AnnexII,et,A,<BIOLOOGILIS(T)E TOIMEAINE(TE) TOOTJA(D) JA> RAVIMIPARTII KASUTAMISEKS VABASTAMISE EEST VASTUTAV(AD) TOOTJA(D),17001.0,True
3,17003,CAP,AnnexII,et,,Bioloogilis(t)e toimeaine(te) tootja(te) nimi (nimed) ja aadress(id),17002.0,False
4,17004,CAP,AnnexII,et,,Ravimipartii kasutamiseks vabastamise eest vastutava(te) tootja(te) nimi ja aadress,17002.0,True
5,17005,CAP,AnnexII,et,B,HANKE- JA KASUTUSTINGIMUSED VÕI PIIRANGUD,17001.0,True
6,17006,CAP,AnnexII,et,,Ravimipartii ametlik kasutamiseks vabastamine,17005.0,False
7,17007,CAP,AnnexII,et,C,MÜÜGILOA MUUD TINGIMUSED JA NÕUDED,17001.0,True
8,17008,CAP,AnnexII,et,,Perioodilised ohutusaruanded,17007.0,True
9,17009,CAP,AnnexII,et,D,RAVIMPREPARAADI OHUTU JA EFEKTIIVSE KASUTAMISE TINGIMUSED JA PIIRANGUD,17001.0,True
10,17010,CAP,AnnexII,et,,Riskijuhtimiskava,17009.0,True
11,17011,CAP,AnnexII,et,,Riski minimeerimise lisameetmed,17009.0,False
12,17012,CAP,AnnexII,et,,Müügiloajärgsed kohustused,17009.0,False
13,17013,CAP,AnnexII,et,E,ERIKOHUSTUSED <TINGIMUSLIKU MÜÜGILOA> <ERANDLIKEL ASJAOLUDEL VÄLJAANTUD MÜÜGILOA> JÄRGSETE MEETMETE TÄITMISEKS,17001.0,False
1,18001,CAP,Labelling,et,,PAKENDI MÄRGISTUS,,True
2,18002,CAP,Labelling,et,,<VÄLISPAKENDIL> <JA> <SISEPAKENDIL> PEAVAD OLEMA JÄRGMISED ANDMED,18001.0,True
3,18003,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,18002.0,True
4,18004,CAP,Labelling,et,2,TOIMEAINE(TE) SISALDUS,18002.0,True
5,18005,CAP,Labelling,et,3,ABIAINED,18002.0,True
6,18006,CAP,Labelling,et,4,RAVIMVORM JA PAKENDI SUURUS,18002.0,True
7,18007,CAP,Labelling,et,5,MANUSTAMISVIIS JA -TEE(D),18002.0,True
8,18008,CAP,Labelling,et,6,"ERIHOIATUS, ET RAVIMIT TULEB HOIDA LASTE EEST VARJATUD JA KÄTTESAAMATUS KOHAS",18002.0,True
9,18009,CAP,Labelling,et,7,TEISED ERIHOIATUSED (VAJADUSEL),18002.0,True
10,18010,CAP,Labelling,et,8,KÕLBLIKKUSAEG,18002.0,True
11,18011,CAP,Labelling,et,9,SÄILITAMISE ERITINGIMUSED,18002.0,True
12,18012,CAP,Labelling,et,10,"ERINÕUDED KASUTAMATA JÄÄNUD RAVIMPREPARAADI VÕI SELLEST TEKKINUD JÄÄTMEMATERJALI HÄVITAMISEKS, VASTAVALT VAJADUSELE",18002.0,True
13,18013,CAP,Labelling,et,11,MÜÜGILOA HOIDJA NIMI JA AADRESS,18002.0,True
14,18014,CAP,Labelling,et,12,MÜÜGILOA NUMBER (NUMBRID),18002.0,True
15,18015,CAP,Labelling,et,13,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,18002.0,True
16,18016,CAP,Labelling,et,14,RAVIMI VÄLJASTAMISTINGIMUSED,18002.0,True
17,18017,CAP,Labelling,et,15,KASUTUSJUHEND,18002.0,True
18,18018,CAP,Labelling,et,16,TEAVE BRAILLE’ KIRJAS (PUNKTKIRJAS),18002.0,True
19,18019,CAP,Labelling,et,17,AINULAADNE IDENTIFIKAATOR – 2D-vöötkood,18002.0,True
20,18020,CAP,Labelling,et,18,AINULAADNE IDENTIFIKAATOR – INIMLOETAVAD ANDMED,18002.0,True
21,18021,CAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA BLISTER- VÕI RIBAPAKENDIL",18001.0,True
22,18022,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS,18021.0,True
23,18023,CAP,Labelling,et,2,MÜÜGILOA HOIDJA NIMI,18021.0,True
24,18024,CAP,Labelling,et,3,KÕLBLIKKUSAEG,18021.0,True
25,18025,CAP,Labelling,et,4,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,18021.0,True
26,18026,CAP,Labelling,et,5,MUU,18021.0,True
27,18027,CAP,Labelling,et,,"MINIMAALSED ANDMED, MIS PEAVAD OLEMA VÄIKESEL VAHETUL SISEPAKENDIL",18001.0,True
28,18028,CAP,Labelling,et,1,RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D),18027.0,True
29,18029,CAP,Labelling,et,2,MANUSTAMISVIIS,18027.0,True
30,18030,CAP,Labelling,et,3,KÕLBLIKKUSAEG,18027.0,True
31,18031,CAP,Labelling,et,4,PARTII NUMBER <ANNETUSE KOOD(ID) JA TOOTEKOOD(ID)>,18027.0,True
32,18032,CAP,Labelling,et,5,"PAKENDI SISU KAALU, MAHU VÕI ÜHIKUTE JÄRGI",18027.0,True
33,18033,CAP,Labelling,et,6,MUU,18027.0,True
1,19001,CAP,Package leaflet,et,,PAKENDI INFOLEHT,,True
2,19002,CAP,Package leaflet,et,,"qSellele ravimile kohaldatakse täiendavat järelevalvet, mis võimaldab kiiresti tuvastada uut ohutusteavet. Te saate sellele kaasa aidata, teatades ravimi kõigist võimalikest kõrvaltoimetest. Kõrvaltoimetest teatamise kohta vt lõik 4.> ",19001.0,False
3,19003,CAP,Package leaflet,et,,Infolehe sisukord,19001.0,True
4,19004,CAP,Package leaflet,et,1,Mis ravim on X ja milleks seda kasutatakse,19001.0,True
5,19005,CAP,Package leaflet,et,2,Mida on vaja teada enne X’i <võtmist> <kasutamist> ,19001.0,True
6,19006,CAP,Package leaflet,et,,X’i ei tohi <võtta> <kasutada>,19005.0,True
7,19007,CAP,Package leaflet,et,,Hoiatused ja ettevaatusabinõud,19005.0,True
8,19008,CAP,Package leaflet,et,,Lapsed <ja noorukid>,19005.0,True
9,19009,CAP,Package leaflet,et,,Muud ravimid ja X,19005.0,True
10,19010,CAP,Package leaflet,et,,"X koos <toidu> <ja> <,> <joogi> <ja> <alkoholiga>",19005.0,True
11,19011,CAP,Package leaflet,et,,"Rasedus <ja> <,> imetamine <ja viljakus>",19005.0,True
12,19012,CAP,Package leaflet,et,,Autojuhtimine ja masinatega töötamine,19005.0,True
13,19013,CAP,Package leaflet,et,,X sisaldab {abiaine(te) nimetus},19005.0,False
14,19014,CAP,Package leaflet,et,3,Kuidas X’i <võtta> <kasutada>,19001.0,True
15,19015,CAP,Package leaflet,et,,Kasutamine lastel <ja noorukitel>,19014.0,False
16,19016,CAP,Package leaflet,et,,"Kui te <võtate> <kasutate> X’i rohkem, kui ette nähtud",19014.0,False
17,19017,CAP,Package leaflet,et,,Kui te unustate X’i <võtta> <kasutada>,19014.0,False
18,19018,CAP,Package leaflet,et,,Kui te lõpetate X’i <võtmise> <kasutamise>,19014.0,False
19,19019,CAP,Package leaflet,et,4,Võimalikud kõrvaltoimed,19001.0,True
20,19020,CAP,Package leaflet,et,,Täiendavad kõrvaltoimed lastel <ja noorukitel>,19019.0,False
21,19021,CAP,Package leaflet,et,,Kõrvaltoimetest teatamine,19019.0,True
22,19022,CAP,Package leaflet,et,5,Kuidas X’i säilitada,19001.0,True
23,19023,CAP,Package leaflet,et,6,Pakendi sisu ja muu teave,19001.0,True
24,19024,CAP,Package leaflet,et,,Mida X sisaldab,19023.0,True
25,19025,CAP,Package leaflet,et,,Kuidas X välja näeb ja pakendi sisu,19023.0,True
26,19026,CAP,Package leaflet,et,,Müügiloa hoidja ja tootja,19023.0,True
27,19027,CAP,Package leaflet,et,,Lisaküsimuste tekkimisel selle ravimi kohta pöörduge palun müügiloa hoidja kohaliku esindaja poole:,19023.0,False
28,19028,CAP,Package leaflet,et,,Infoleht on viimati uuendatud <KK.AAAA> <kuu AAAA>.,19023.0,True
29,19029,CAP,Package leaflet,et,,Muud teabeallikad,19023.0,False
30,19030,CAP,Package leaflet,et,,Järgmine teave on ainult tervishoiutöötajatele:,19001.0,False
1,20001,CAP,SmPC,nl,,SAMENVATTING VAN DE PRODUCTKENMERKEN,,True
2,20002,CAP,SmPC,nl,,qDit geneesmiddel is onderworpen aan aanvullende monitoring.  Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. Beroepsbeoefenaren in de gezondheidszorg wordt verzocht alle vermoedelijke bijwerkingen te melden. Zie rubriek 4.8 voor het rapporteren van bijwerkingen,20001.0,False
3,20003,CAP,SmPC,nl,1,NAAM VAN HET GENEESMIDDEL,20001.0,True
4,20004,CAP,SmPC,nl,2,KWALITATIEVE EN KWANTITATIEVE SAMENSTELLING,20001.0,True
5,20005,CAP,SmPC,nl,2.1,Algemene beschrijving,20004.0,False
6,20006,CAP,SmPC,nl,2.2,Kwalitatieve en kwantitatieve samenstelling,20004.0,False
7,20007,CAP,SmPC,nl,,Hulpstof(fen) met bekend effect,20006.0,False
8,20008,CAP,SmPC,nl,3,FARMACEUTISCHE VORM,20001.0,True
9,20009,CAP,SmPC,nl,4,KLINISCHE GEGEVENS,20001.0,True
10,20010,CAP,SmPC,nl,4.1,Therapeutische indicaties,20009.0,True
11,20011,CAP,SmPC,nl,4.2,Dosering en wijze van toediening,20009.0,True
12,20012,CAP,SmPC,nl,,Dosering,20011.0,True
13,20013,CAP,SmPC,nl,,Pediatrische patiënten,20012.0,True
14,20014,CAP,SmPC,nl,,Wijze van toediening,20011.0,True
15,20015,CAP,SmPC,nl,,Te nemen voorzorgen voorafgaand aan gebruik of toediening van het geneesmiddel,20014.0,False
16,20016,CAP,SmPC,nl,4.3,Contra-indicaties,20009.0,True
17,20017,CAP,SmPC,nl,4.4,Bijzondere waarschuwingen en voorzorgen bij gebruik,20009.0,True
18,20018,CAP,SmPC,nl,,Terugvinden herkomst,20017.0,False
19,20019,CAP,SmPC,nl,,Pediatrische patiënten,20017.0,False
20,20020,CAP,SmPC,nl,4.5,Interacties met andere geneesmiddelen en andere vormen van interactie,20009.0,True
21,20021,CAP,SmPC,nl,,Pediatrische patiënten,20020.0,False
22,20022,CAP,SmPC,nl,4.6,"Vruchtbaarheid, zwangerschap en borstvoeding",20009.0,True
23,20023,CAP,SmPC,nl,,Zwangerschap,20022.0,False
24,20024,CAP,SmPC,nl,,Borstvoeding,20022.0,False
25,20025,CAP,SmPC,nl,,Vruchtbaarheid,20022.0,False
26,20026,CAP,SmPC,nl,4.7,Beïnvloeding van de rijvaardigheid en het vermogen om machines te bedienen,20009.0,True
27,20027,CAP,SmPC,nl,4.8,Bijwerkingen,20009.0,True
28,20028,CAP,SmPC,nl,,Pediatrische patiënten,20027.0,False
29,20029,CAP,SmPC,nl,,Melding van vermoedelijke bijwerkingen,20027.0,True
30,20030,CAP,SmPC,nl,4.9,Overdosering,20009.0,True
31,20031,CAP,SmPC,nl,,Pediatrische patiënten,20030.0,False
32,20032,CAP,SmPC,nl,5,FARMACOLOGISCHE EIGENSCHAPPEN,20001.0,True
33,20033,CAP,SmPC,nl,5.1,Farmacodynamische eigenschappen,20032.0,True
34,20034,CAP,SmPC,nl,,Werkingsmechanisme,20033.0,False
35,20035,CAP,SmPC,nl,,Farmacodynamische effecten,20033.0,False
36,20036,CAP,SmPC,nl,,Klinische werkzaamheid en veiligheid,20033.0,False
37,20037,CAP,SmPC,nl,,Pediatrische patiënten,20033.0,False
38,20038,CAP,SmPC,nl,5.2,Farmacokinetische eigenschappen,20032.0,True
39,20039,CAP,SmPC,nl,,Absorptie,20038.0,False
40,20040,CAP,SmPC,nl,,Distributie,20038.0,False
41,20041,CAP,SmPC,nl,,Biotransformatie,20038.0,False
42,20042,CAP,SmPC,nl,,Eliminatie,20038.0,False
43,20043,CAP,SmPC,nl,,Lineariteit/non-lineariteit,20038.0,False
44,20044,CAP,SmPC,nl,,Farmacokinetische/farmacodynamische relatie(s),20038.0,False
45,20045,CAP,SmPC,nl,5.3,Gegevens uit het preklinisch veiligheidsonderzoek,20032.0,True
46,20046,CAP,SmPC,nl,,Environmental risk assessment (ERA),20045.0,False
47,20047,CAP,SmPC,nl,6,FARMACEUTISCHE GEGEVENS,20001.0,True
48,20048,CAP,SmPC,nl,6.1,Lijst van hulpstoffen,20047.0,True
49,20049,CAP,SmPC,nl,6.2,Gevallen van onverenigbaarheid,20047.0,True
50,20050,CAP,SmPC,nl,6.3,Houdbaarheid,20047.0,True
51,20051,CAP,SmPC,nl,6.4,Speciale voorzorgsmaatregelen bij bewaren,20047.0,True
52,20052,CAP,SmPC,nl,6.5,"Aard en inhoud van de verpakking <en speciale benodigdheden voor gebruik, toediening of implantatie>",20047.0,True
53,20053,CAP,SmPC,nl,6.6,Speciale voorzorgsmaatregelen voor het verwijderen <en andere instructies>,20047.0,True
54,20054,CAP,SmPC,nl,,Gebruik bij pediatrische patiënten,20053.0,False
55,20055,CAP,SmPC,nl,7,HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,20001.0,True
56,20056,CAP,SmPC,nl,8,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,20001.0,True
57,20057,CAP,SmPC,nl,9,DATUM VAN EERSTE VERLENING VAN DE VERGUNNING/VERLENGING VAN DE VERGUNNING,20001.0,True
58,20058,CAP,SmPC,nl,10,DATUM VAN HERZIENING VAN DE TEKST,20001.0,True
59,20059,CAP,SmPC,nl,11,DOSIMETRIE,20001.0,False
60,20060,CAP,SmPC,nl,12,INSTRUCTIES VOOR DE BEREIDING VAN RADIOACTIEVE GENEESMIDDELEN,20001.0,False
1,21001,CAP,BIJLAGE II,nl,,BIJLAGE II,,True
2,21002,CAP,BIJLAGE II,nl,A,<FABRIKANT(EN) VAN DE BIOLOGISCH WERKZAME STOF(FEN) EN >FABRIKANT(EN) VERANTWOORDELIJK VOOR VRIJGIFTE,21001.0,True
3,21003,CAP,BIJLAGE II,nl,,Naam en adres van de fabrikant(en) van de biologisch werkzame stof(fen),21002.0,False
4,21004,CAP,BIJLAGE II,nl,,Naam en adres van de fabrikant(en) verantwoordelijk voor vrijgifte,21002.0,True
5,21005,CAP,BIJLAGE II,nl,B,VOORWAARDEN OF BEPERKINGEN TEN AANZIEN VAN LEVERING EN GEBRUIK,21001.0,True
6,21006,CAP,BIJLAGE II,nl,,Officiële vrijgifte van de batch,21005.0,False
7,21007,CAP,BIJLAGE II,nl,C,ANDERE VOORWAARDEN EN EISEN DIE DOOR DE HOUDER VAN DE HANDELSVERGUNNING MOETEN WORDEN NAGEKOMEN,21001.0,True
8,21008,CAP,BIJLAGE II,nl,,Periodieke veiligheidsverslagen ,21007.0,True
9,21009,CAP,BIJLAGE II,nl,D,VOORWAARDEN OF BEPERKINGEN MET BETREKKING TOT EEN VEILIG EN DOELTREFFEND GEBRUIK VAN HET GENEESMIDDEL,21001.0,True
10,21010,CAP,BIJLAGE II,nl,,Risk management plan (RMP),21009.0,True
11,21011,CAP,BIJLAGE II,nl,,Extra risicobeperkende maatregelen,21009.0,False
12,21012,CAP,BIJLAGE II,nl,,Verplichting tot het nemen van maatregelen na toekenning van de handelsvergunning,21009.0,False
13,21013,CAP,BIJLAGE II,nl,E,SPECIFIEKE VERPLICHTINGEN WAARAAN NA TOEKENNING VAN EEN <VOORWAARDELIJKE VERGUNNING> <VERGUNNING ONDER UITZONDERLIJKE VOORWAARDEN> MOET WORDEN VOLDAAN,21001.0,False
1,22001,CAP,ETIKETTERING,nl,,ETIKETTERING,,True
2,22002,CAP,ETIKETTERING,nl,,GEGEVENS DIE OP <DE BUITENVERPAKKING><EN> <DE PRIMAIRE VERPAKKING> MOETEN WORDEN VERMELD,22001.0,True
3,22003,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL,22002.0,True
4,22004,CAP,ETIKETTERING,nl,2,GEHALTE AAN WERKZAME STOF(FEN),22002.0,True
5,22005,CAP,ETIKETTERING,nl,3,LIJST VAN HULPSTOFFEN,22002.0,True
6,22006,CAP,ETIKETTERING,nl,4,FARMACEUTISCHE VORM EN INHOUD,22002.0,True
7,22007,CAP,ETIKETTERING,nl,5,WIJZE VAN GEBRUIK EN TOEDIENINGSWEG(EN),22002.0,True
8,22008,CAP,ETIKETTERING,nl,6,EEN SPECIALE WAARSCHUWING DAT HET GENEESMIDDEL BUITEN HET ZICHT EN BEREIK VAN KINDEREN DIENT TE WORDEN GEHOUDEN,22002.0,True
9,22009,CAP,ETIKETTERING,nl,7,"ANDERE SPECIALE WAARSCHUWING(EN), INDIEN NODIG",22002.0,True
10,22010,CAP,ETIKETTERING,nl,8,UITERSTE GEBRUIKSDATUM,22002.0,True
11,22011,CAP,ETIKETTERING,nl,9,BIJZONDERE VOORZORGSMAATREGELEN VOOR DE BEWARING,22002.0,True
12,22012,CAP,ETIKETTERING,nl,10,BIJZONDERE VOORZORGSMAATREGELEN VOOR HET VERWIJDEREN VAN NIET-GEBRUIKTE GENEESMIDDELEN OF DAARVAN AFGELEIDE AFVALSTOFFEN (INDIEN VAN TOEPASSING),22002.0,True
13,22013,CAP,ETIKETTERING,nl,11,NAAM EN ADRES VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,22002.0,True
14,22014,CAP,ETIKETTERING,nl,12,NUMMER(S) VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN ,22002.0,True
15,22015,CAP,ETIKETTERING,nl,13,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",22002.0,True
16,22016,CAP,ETIKETTERING,nl,14,ALGEMENE INDELING VOOR DE AFLEVERING,22002.0,True
17,22017,CAP,ETIKETTERING,nl,15,INSTRUCTIES VOOR GEBRUIK,22002.0,True
18,22018,CAP,ETIKETTERING,nl,16,INFORMATIE IN BRAILLE,22002.0,True
19,22019,CAP,ETIKETTERING,nl,17,UNIEK IDENTIFICATIEKENMERK - 2D MATRIXCODE,22002.0,True
20,22020,CAP,ETIKETTERING,nl,18,UNIEK IDENTIFICATIEKENMERK - VOOR MENSEN LEESBARE GEGEVENS,22002.0,True
21,22021,CAP,ETIKETTERING,nl,,GEGEVENS DIE IN IEDER GEVAL OP BLISTERVERPAKKINGEN OF STRIPS MOETEN WORDEN VERMELD,22001.0,True
22,22022,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL,22021.0,True
23,22023,CAP,ETIKETTERING,nl,2,NAAM VAN DE HOUDER VAN DE VERGUNNING VOOR HET IN DE HANDEL BRENGEN,22021.0,True
24,22024,CAP,ETIKETTERING,nl,3,UITERSTE GEBRUIKSDATUM,22021.0,True
25,22025,CAP,ETIKETTERING,nl,4,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",22021.0,True
26,22026,CAP,ETIKETTERING,nl,5,OVERIGE,22021.0,True
27,22027,CAP,ETIKETTERING,nl,,GEGEVENS DIE IN IEDER GEVAL OP PRIMAIRE KLEINVERPAKKINGEN MOETEN WORDEN VERMELD,22001.0,True
28,22028,CAP,ETIKETTERING,nl,1,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),22027.0,True
29,22029,CAP,ETIKETTERING,nl,2,NAAM VAN HET GENEESMIDDEL EN DE TOEDIENINGSWEG(EN),22027.0,True
30,22030,CAP,ETIKETTERING,nl,3,UITERSTE GEBRUIKSDATUM,22027.0,True
31,22031,CAP,ETIKETTERING,nl,4,"PARTIJNUMMER<, IDENTIFICATIE- EN PRODUCTCODES>",22027.0,True
32,22032,CAP,ETIKETTERING,nl,5,"INHOUD UITGEDRUKT IN GEWICHT, VOLUME OF EENHEID",22027.0,True
33,22033,CAP,ETIKETTERING,nl,6,OVERIGE,22027.0,True
1,23001,CAP,BIJSLUITER,nl,,BIJSLUITER,,True
2,23002,CAP,BIJSLUITER,nl,,q Dit geneesmiddel is onderworpen aan aanvullende monitoring. Daardoor kan snel nieuwe veiligheidsinformatie worden vastgesteld. U kunt hieraan bijdragen door melding te maken van alle bijwerkingen die u eventueel zou ervaren. Aan het einde van rubriek 4 leest u hoe u dat kunt doen,23001.0,False
3,23003,CAP,BIJSLUITER,nl,,Inhoud van deze bijsluiter,23001.0,True
4,23004,CAP,BIJSLUITER,nl,1,Wat is X en waarvoor wordt dit middel <gebruikt><ingenomen>?,23001.0,True
5,23005,CAP,BIJSLUITER,nl,2,Wanneer mag u dit middel niet <gebruiken><innemen> of moet u er extra voorzichtig mee zijn?,23001.0,True
6,23006,CAP,BIJSLUITER,nl,,Wanneer mag u dit middel niet gebruiken?,23005.0,True
7,23007,CAP,BIJSLUITER,nl,,Wanneer moet u extra voorzichtig zijn met dit middel?,23005.0,True
8,23008,CAP,BIJSLUITER,nl,,Kinderen <en jongeren tot 18 jaar>,23005.0,True
9,23009,CAP,BIJSLUITER,nl,,<Gebruikt u nog andere geneesmiddelen?><Neemt u nog andere geneesmiddelen in?>,23005.0,True
10,23010,CAP,BIJSLUITER,nl,,"Waarop moet u letten met <eten> <en> <,> <drinken> <en> <alcohol>?",23005.0,True
11,23011,CAP,BIJSLUITER,nl,,"Zwangerschap <en> <,> borstvoeding <en vruchtbaarheid>",23005.0,True
12,23012,CAP,BIJSLUITER,nl,,Rijvaardigheid en het gebruik van machines,23005.0,True
13,23013,CAP,BIJSLUITER,nl,,X bevat {naam van de hulpstof(fen)},23005.0,False
14,23014,CAP,BIJSLUITER,nl,3,Hoe <gebruikt u dit middel><neemt u dit middel in>?,23001.0,True
15,23015,CAP,BIJSLUITER,nl,,Gebruik bij kinderen <en jongeren tot 18 jaar>,23014.0,False
16,23016,CAP,BIJSLUITER,nl,,Heeft u te veel van dit middel <gebruikt> <ingenomen>?,23014.0,False
17,23017,CAP,BIJSLUITER,nl,,Bent u vergeten dit middel <te gebruiken> <in te nemen>?,23014.0,False
18,23018,CAP,BIJSLUITER,nl,,Als u stopt met het <innemen> <gebruik> van dit middel,23014.0,False
19,23019,CAP,BIJSLUITER,nl,4,Mogelijke bijwerkingen,23001.0,True
20,23020,CAP,BIJSLUITER,nl,,Extra bijwerkingen die bij kinderen <en jongeren tot 18 jaar> kunnen voorkomen,23019.0,False
21,23021,CAP,BIJSLUITER,nl,,Het melden van bijwerkingen,23019.0,True
22,23022,CAP,BIJSLUITER,nl,5,Hoe bewaart u dit middel?,23001.0,True
23,23023,CAP,BIJSLUITER,nl,6,Inhoud van de verpakking en overige informatie,23001.0,True
24,23024,CAP,BIJSLUITER,nl,,Welke stoffen zitten er in dit middel?,23023.0,True
25,23025,CAP,BIJSLUITER,nl,,Hoe ziet X eruit en hoeveel zit er in een verpakking?,23023.0,True
26,23026,CAP,BIJSLUITER,nl,,Houder van de vergunning voor het in de handel brengen en fabrikant,23023.0,True
27,23027,CAP,BIJSLUITER,nl,,Neem voor alle informatie over dit geneesmiddel contact op met de lokale vertegenwoordiger van de houder van de vergunning voor het in de handel brengen:,23023.0,False
28,23028,CAP,BIJSLUITER,nl,,Deze bijsluiter is voor het laatst goedgekeurd in <{MM/JJJJ}> <{maand JJJJ}>.,23023.0,True
29,23029,CAP,BIJSLUITER,nl,,Andere informatiebronnen,23023.0,False
30,23030,CAP,BIJSLUITER,nl,,De volgende informatie is alleen bestemd voor beroepsbeoefenaren in de gezondheidszorg:,23001.0,False
1,24001,CAP,SmPC,se,,PRODUKTRESUMÉ,,True
2,24002,CAP,SmPC,se,,qDetta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Hälso- och sjukvårdspersonal uppmanas att rapportera varje misstänkt biverkning. Se avsnitt 4.8 om hur man rapporterar biverkningar.,24001.0,False
3,24003,CAP,SmPC,se,1,LÄKEMEDLETS NAMN,24001.0,True
4,24004,CAP,SmPC,se,2,KVALITATIV OCH KVANTITATIV SAMMANSÄTTNING,24001.0,True
5,24005,CAP,SmPC,se,2.1,Allmän beskrivning,24004.0,False
6,24006,CAP,SmPC,se,2.2,Kvalitativ och kvantitativ sammansättning,24004.0,False
7,24007,CAP,SmPC,se,,Hjälpämne(n) med känd effekt,24006.0,False
8,24008,CAP,SmPC,se,3,LÄKEMEDELSFORM,24001.0,True
9,24009,CAP,SmPC,se,4,KLINISKA UPPGIFTER,24001.0,True
10,24010,CAP,SmPC,se,4.1,Terapeutiska indikationer,24009.0,True
11,24011,CAP,SmPC,se,4.2,Dosering och administreringssätt,24009.0,True
12,24012,CAP,SmPC,se,,Dosering,24011.0,True
13,24013,CAP,SmPC,se,,Pediatrisk population,24012.0,True
14,24014,CAP,SmPC,se,,Administreringssätt,24011.0,True
15,24015,CAP,SmPC,se,,Försiktighetsåtgärder före hantering eller administrering av läkemedlet,24014.0,False
16,24016,CAP,SmPC,se,4.3,Kontraindikationer,24009.0,True
17,24017,CAP,SmPC,se,4.4,Varningar och försiktighet,24009.0,True
18,24018,CAP,SmPC,se,,Spårbarhet,24017.0,False
19,24019,CAP,SmPC,se,,Pediatrisk population,24017.0,False
20,24020,CAP,SmPC,se,4.5,Interaktioner med andra läkemedel och övriga interaktioner,24009.0,True
21,24021,CAP,SmPC,se,,Pediatrisk population,24020.0,False
22,24022,CAP,SmPC,se,4.6,"Fertilitet, graviditet och amning",24009.0,True
23,24023,CAP,SmPC,se,,Graviditet,24022.0,False
24,24024,CAP,SmPC,se,,Amning,24022.0,False
25,24025,CAP,SmPC,se,,Fertilitet,24022.0,False
26,24026,CAP,SmPC,se,4.7,Effekter på förmågan att framföra fordon och använda maskiner,24009.0,True
27,24027,CAP,SmPC,se,4.8,Biverkningar,24009.0,True
28,24028,CAP,SmPC,se,,Pediatrisk population,24027.0,False
29,24029,CAP,SmPC,se,,Rapportering av misstänkta biverkningar,24027.0,True
30,24030,CAP,SmPC,se,4.9,Överdosering,24009.0,True
31,24031,CAP,SmPC,se,,Pediatrisk population,24030.0,False
32,24032,CAP,SmPC,se,5,FARMAKOLOGISKA EGENSKAPER,24001.0,True
33,24033,CAP,SmPC,se,5.1,Farmakodynamiska egenskaper,24032.0,True
34,24034,CAP,SmPC,se,,Verkningsmekanism,24033.0,False
35,24035,CAP,SmPC,se,,Farmakodynamisk effekt,24033.0,False
36,24036,CAP,SmPC,se,,Klinisk effekt och säkerhet,24033.0,False
37,24037,CAP,SmPC,se,,Pediatrisk population,24033.0,False
38,24038,CAP,SmPC,se,5.2,Farmakokinetiska egenskaper,24032.0,True
39,24039,CAP,SmPC,se,,Absorption,24038.0,False
40,24040,CAP,SmPC,se,,Distribution,24038.0,False
41,24041,CAP,SmPC,se,,Metabolism,24038.0,False
42,24042,CAP,SmPC,se,,Eliminering,24038.0,False
43,24043,CAP,SmPC,se,,Linjäritet/icke-linjäritet,24038.0,False
44,24044,CAP,SmPC,se,,Farmakokinetiskt (Farmakokinetiska)/farmakodynamiskt (farmakodynamiska) förhållande(n),24038.0,False
45,24045,CAP,SmPC,se,5.3,Prekliniska säkerhetsuppgifter,24032.0,True
46,24046,CAP,SmPC,se,,Miljöriskbedömning,24045.0,False
47,24047,CAP,SmPC,se,6,FARMACEUTISKA UPPGIFTER,24001.0,True
48,24048,CAP,SmPC,se,6.1,Förteckning över hjälpämnen,24047.0,True
49,24049,CAP,SmPC,se,6.2,Inkompatibiliteter,24047.0,True
50,24050,CAP,SmPC,se,6.3,Hållbarhet,24047.0,True
51,24051,CAP,SmPC,se,6.4,Särskilda förvaringsanvisningar,24047.0,True
52,24052,CAP,SmPC,se,6.5,"Förpackningstyp och innehåll <och utrustning för användning, administrering eller implantation>",24047.0,True
53,24053,CAP,SmPC,se,6.6,Särskilda anvisningar för destruktion <och övrig hantering>,24047.0,True
54,24054,CAP,SmPC,se,,Användning i den pediatriska populationen,24053.0,False
55,24055,CAP,SmPC,se,7,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,24001.0,True
56,24056,CAP,SmPC,se,8,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,24001.0,True
57,24057,CAP,SmPC,se,9,DATUM FÖR FÖRSTA GODKÄNNANDE/FÖRNYAT GODKÄNNANDE,24001.0,True
58,24058,CAP,SmPC,se,10,DATUM FÖR ÖVERSYN AV PRODUKTRESUMÉN,24001.0,True
59,24059,CAP,SmPC,se,11,ABSORBERAD DOS OCH EFFEKTIV DOS,24001.0,False
60,24060,CAP,SmPC,se,12,INSTRUKTION FÖR BEREDNING AV RADIOFARMAKA,24001.0,False
1,25001,CAP,AnnexII,se,,BILAGA II,,True
2,25002,CAP,AnnexII,se,A,< TILLVERKARE AV DEN (DE) AKTIVA SUBSTANSEN (SUBSTANSERNA) AV BIOLOGISKT URSPRUNG OCH > TILLVERKARE SOM ANSVARAR FÖR FRISLÄPPANDE AV TILLVERKNINGSSATS,25001.0,True
3,25003,CAP,AnnexII,se,,Namn och adress till tillverkare av aktiv(a) substans(er) av biologiskt ursprung,25002.0,False
4,25004,CAP,AnnexII,se,,Namn och adress till tillverkare som ansvarar för frisläppande av tillverkningssats,25002.0,True
5,25005,CAP,AnnexII,se,B,VILLKOR ELLER BEGRÄNSNINGAR FÖR TILLHANDAHÅLLANDE OCH ANVÄNDNING ,25001.0,True
6,25006,CAP,AnnexII,se,,Officiellt frisläppande av tillverkningssats,25005.0,False
7,25007,CAP,AnnexII,se,C,ÖVRIGA VILLKOR OCH KRAV FÖR GODKÄNNANDET FÖR FÖRSÄLJNING,25001.0,True
8,25008,CAP,AnnexII,se,,Periodiska säkerhetsrapporter,25007.0,True
9,25009,CAP,AnnexII,se,D,VILLKOR ELLER BEGRÄNSNINGAR AVSEENDE EN SÄKER OCH EFFEKTIV ANVÄNDNING AV LÄKEMEDLET  ,25001.0,True
10,25010,CAP,AnnexII,se,,Riskhanteringsplan,25009.0,True
11,25011,CAP,AnnexII,se,,Ytterligare riskminimeringsåtgärder,25009.0,False
12,25012,CAP,AnnexII,se,,Skyldighet att vidta åtgärder efter godkännande för försäljning,25009.0,False
13,25013,CAP,AnnexII,se,E,SÄRSKILDA VILLKOR SOM SKA KOMPLETTERA ÅTAGANDEN EFTER GODKÄNNANDET FÖR FÖRSÄLJNING <FÖR DET VILLKORADE GODKÄNNANDET> <FÖR GODKÄNNANDET I UNDANTAGSFALL>,25001.0,False
1,26001,CAP,Labelling,se,,MÄRKNING,,True
2,26002,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ <YTTRE FÖRPACKNINGEN> <OCH PÅ> <INNERFÖRPACKNINGEN>,26001.0,True
3,26003,CAP,Labelling,se,1,LÄKEMEDLETS NAMN,26002.0,True
4,26004,CAP,Labelling,se,2,DEKLARATION AV AKTIV(A) SUBSTANS(ER),26002.0,True
5,26005,CAP,Labelling,se,3,FÖRTECKNING ÖVER HJÄLPÄMNEN,26002.0,True
6,26006,CAP,Labelling,se,4,LÄKEMEDELSFORM OCH FÖRPACKNINGSSTORLEK,26002.0,True
7,26007,CAP,Labelling,se,5,ADMINISTRERINGSSÄTT OCH ADMINISTRERINGSVÄG,26002.0,True
8,26008,CAP,Labelling,se,6,SÄRSKILD VARNING OM ATT LÄKEMEDLET MÅSTE FÖRVARAS UTOM SYN- OCH RÄCKHÅLL FÖR BARN,26002.0,True
9,26009,CAP,Labelling,se,7,ÖVRIGA SÄRSKILDA VARNINGAR OM SÅ ÄR NÖDVÄNDIGT,26002.0,True
10,26010,CAP,Labelling,se,8,UTGÅNGSDATUM,26002.0,True
11,26011,CAP,Labelling,se,9,SÄRSKILDA FÖRVARINGSANVISNINGAR,26002.0,True
12,26012,CAP,Labelling,se,10,SÄRSKILDA FÖRSIKTIGHETSÅTGÄRDER FÖR DESTRUKTION AV EJ ANVÄNT LÄKEMEDEL OCH AVFALL I FÖREKOMMANDE FALL,26002.0,True
13,26013,CAP,Labelling,se,11,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING (NAMN OCH ADRESS),26002.0,True
14,26014,CAP,Labelling,se,12,NUMMER PÅ GODKÄNNANDE FÖR FÖRSÄLJNING ,26002.0,True
15,26015,CAP,Labelling,se,13,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER>",26002.0,True
16,26016,CAP,Labelling,se,14,ALLMÄN KLASSIFICERING FÖR FÖRSKRIVNING,26002.0,True
17,26017,CAP,Labelling,se,15,BRUKSANVISNING,26002.0,True
18,26018,CAP,Labelling,se,16,INFORMATION I PUNKTSKRIFT,26002.0,True
19,26019,CAP,Labelling,se,17,UNIK IDENTITETSBETECKNING – TVÅDIMENSIONELL STRECKKOD ,26002.0,True
20,26020,CAP,Labelling,se,18,UNIK IDENTITETSBETECKNING – I ETT FORMAT LÄSBART FÖR MÄNSKLIGT ÖGA,26002.0,True
21,26021,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ BLISTER ELLER STRIPS,26001.0,True
22,26022,CAP,Labelling,se,1,LÄKEMEDLETS NAMN,26021.0,True
23,26023,CAP,Labelling,se,2,INNEHAVARE AV GODKÄNNANDE FÖR FÖRSÄLJNING,26021.0,True
24,26024,CAP,Labelling,se,3,UTGÅNGSDATUM,26021.0,True
25,26025,CAP,Labelling,se,4,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER",26021.0,True
26,26026,CAP,Labelling,se,5,ÖVRIGT,26021.0,True
27,26027,CAP,Labelling,se,,UPPGIFTER SOM SKA FINNAS PÅ SMÅ INRE LÄKEMEDELSFÖRPACKNINGAR,26001.0,True
28,26028,CAP,Labelling,se,1,LÄKEMEDLETS NAMN OCH ADMINISTRERINGSVÄG,26027.0,True
29,26029,CAP,Labelling,se,2,ADMINISTRERINGSSÄTT,26027.0,True
30,26030,CAP,Labelling,se,3,UTGÅNGSDATUM,26027.0,True
31,26031,CAP,Labelling,se,4,"TILLVERKNINGSSATSNUMMER <, DONATIONS- OCH PRODUKTKODER>",26027.0,True
32,26032,CAP,Labelling,se,5,"MÄNGD UTTRYCKT I VIKT, VOLYM ELLER PER ENHET",26027.0,True
33,26033,CAP,Labelling,se,6,ÖVRIGT,26027.0,True
1,27001,CAP,Package leaflet,se,,BIPACKSEDEL,,True
2,27002,CAP,Package leaflet,se,,q Detta läkemedel är föremål för utökad övervakning. Detta kommer att göra det möjligt att snabbt identifiera ny säkerhetsinformation. Du kan hjälpa till genom att rapportera de biverkningar du eventuellt får. Information om hur du rapporterar biverkningar finns i slutet av avsnitt 4. ,27001.0,False
3,27003,CAP,Package leaflet,se,,I denna bipacksedel finns information om följande:,27001.0,True
4,27004,CAP,Package leaflet,se,1,Vad X är och vad det används för,27001.0,True
5,27005,CAP,Package leaflet,se,2,Vad du behöver veta innan du <tar> <använder> X ,27001.0,True
6,27006,CAP,Package leaflet,se,,<Ta> <Använd> inte X<:>,27005.0,True
7,27007,CAP,Package leaflet,se,,Varningar och försiktighet,27005.0,True
8,27008,CAP,Package leaflet,se,,Barn <och ungdomar>,27005.0,True
9,27009,CAP,Package leaflet,se,,Andra läkemedel och X,27005.0,True
10,27010,CAP,Package leaflet,se,,"X med <mat> <och > <,> <dryck> <och> <alkohol>",27005.0,True
11,27011,CAP,Package leaflet,se,,"Graviditet <och> <,> amning <och fertilitet>",27005.0,True
12,27012,CAP,Package leaflet,se,,Körförmåga och användning av maskiner,27005.0,True
13,27013,CAP,Package leaflet,se,,X innehåller {namn på hjälpämne(n)},27005.0,False
14,27014,CAP,Package leaflet,se,3,Hur du <tar> <använder> X,27001.0,True
15,27015,CAP,Package leaflet,se,,Användning för barn <och ungdomar>,27014.0,False
16,27016,CAP,Package leaflet,se,,Om du <har tagit> <använt> för stor mängd av X,27014.0,False
17,27017,CAP,Package leaflet,se,,Om du har glömt att <ta> <använda> X,27014.0,False
18,27018,CAP,Package leaflet,se,,Om du slutar att <ta> <använda>X,27014.0,False
19,27019,CAP,Package leaflet,se,4,Eventuella biverkningar,27001.0,True
20,27020,CAP,Package leaflet,se,,Ytterligare biverkningar hos barn <och ungdomar>,27019.0,False
21,27021,CAP,Package leaflet,se,,Rapportering av biverkningar,27019.0,True
22,27022,CAP,Package leaflet,se,5,Hur X ska förvaras,27001.0,True
23,27023,CAP,Package leaflet,se,6,Förpackningens innehåll och övriga upplysningar,27001.0,True
24,27024,CAP,Package leaflet,se,,Innehållsdeklaration,27023.0,True
25,27025,CAP,Package leaflet,se,,Läkemedlets utseende och förpackningsstorlekar,27023.0,True
26,27026,CAP,Package leaflet,se,,Innehavare av godkännande för försäljning och tillverkare,27023.0,True
27,27027,CAP,Package leaflet,se,,Kontakta ombudet för innehavaren av godkännandet för försäljning om du vill veta mer om detta läkemedel,27023.0,False
28,27028,CAP,Package leaflet,se,,Denna bipacksedel ändrades senast <{MM/ÅÅÅÅ}><{månad ÅÅÅÅ}>.,27023.0,True
29,27029,CAP,Package leaflet,se,,Övriga informationskällor,27023.0,False
30,27030,CAP,Package leaflet,se,,Följande uppgifter är endast avsedda för hälso- och sjukvårdspersonal:,27001.0,False
1,28001,CAP,SmPC,en,,SUMMARY OF PRODUCT CHARACTERISTICS,,True
2,28002,CAP,SmPC,en,,qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.,28001.0,False
3,28003,CAP,SmPC,en,1,NAME OF THE MEDICINAL PRODUCT,28001.0,True
4,28004,CAP,SmPC,en,2,QUALITATIVE AND QUANTITATIVE COMPOSITION,28001.0,True
5,28005,CAP,SmPC,en,2.1,General description,28004.0,False
6,28006,CAP,SmPC,en,2.2,Qualitative and quantitative composition,28004.0,False
7,28007,CAP,SmPC,en,,Excipient(s) with known effect,28006.0,False
8,28008,CAP,SmPC,en,3,PHARMACEUTICAL FORM,28001.0,True
9,28009,CAP,SmPC,en,4,CLINICAL PARTICULARS,28001.0,True
10,28010,CAP,SmPC,en,4.1,Therapeutic indications,28009.0,True
11,28011,CAP,SmPC,en,4.2,Posology and method of administration,28009.0,True
12,28012,CAP,SmPC,en,,Posology,28011.0,True
13,28013,CAP,SmPC,en,,Paediatric population,28012.0,True
14,28014,CAP,SmPC,en,,Method of administration ,28011.0,True
15,28015,CAP,SmPC,en,,Precautions to be taken before handling or administering the medicinal product,28014.0,False
16,28016,CAP,SmPC,en,4.3,Contraindications,28009.0,True
17,28017,CAP,SmPC,en,4.4,Special warnings and precautions for use,28009.0,True
18,28018,CAP,SmPC,en,,Traceability,28017.0,False
19,28019,CAP,SmPC,en,,Paediatric population,28017.0,False
20,28020,CAP,SmPC,en,4.5,Interaction with other medicinal products and other forms of interaction,28009.0,True
21,28021,CAP,SmPC,en,,Paediatric population,28020.0,False
22,28022,CAP,SmPC,en,4.6,"Fertility, pregnancy and lactation",28009.0,True
23,28023,CAP,SmPC,en,,Pregnancy,28022.0,False
24,28024,CAP,SmPC,en,,Breast-feeding,28022.0,False
25,28025,CAP,SmPC,en,,Fertility,28022.0,False
26,28026,CAP,SmPC,en,4.7,Effects on ability to drive and use machines,28009.0,True
27,28027,CAP,SmPC,en,4.8,Undesirable effects,28009.0,True
28,28028,CAP,SmPC,en,,Paediatric population,28027.0,False
29,28029,CAP,SmPC,en,,Reporting of suspected adverse reactions,28027.0,True
30,28030,CAP,SmPC,en,4.9,Overdose,28009.0,True
31,28031,CAP,SmPC,en,,Paediatric population,28030.0,False
32,28032,CAP,SmPC,en,5,PHARMACOLOGICAL PROPERTIES,28001.0,True
33,28033,CAP,SmPC,en,5.1,Pharmacodynamic properties,28032.0,True
34,28034,CAP,SmPC,en,,Mechanism of action,28033.0,False
35,28035,CAP,SmPC,en,,Pharmacodynamic effects,28033.0,False
36,28036,CAP,SmPC,en,,Clinical efficacy and safety,28033.0,False
37,28037,CAP,SmPC,en,,Paediatric population,28033.0,False
38,28038,CAP,SmPC,en,5.2,Pharmacokinetic properties,28032.0,True
39,28039,CAP,SmPC,en,,Absorption,28038.0,False
40,28040,CAP,SmPC,en,,Distribution,28038.0,False
41,28041,CAP,SmPC,en,,Biotransformation,28038.0,False
42,28042,CAP,SmPC,en,,Elimination,28038.0,False
43,28043,CAP,SmPC,en,,Linearity/non-linearity,28038.0,False
44,28044,CAP,SmPC,en,,Pharmacokinetic/pharmacodynamic relationship(s),28038.0,False
45,28045,CAP,SmPC,en,5.3,Preclinical safety data,28032.0,True
46,28046,CAP,SmPC,en,,Environmental risk assessment (ERA),28045.0,False
47,28047,CAP,SmPC,en,6,PHARMACEUTICAL PARTICULARS,28001.0,True
48,28048,CAP,SmPC,en,6.1,List of excipients,28047.0,True
49,28049,CAP,SmPC,en,6.2,Incompatibilities,28047.0,True
50,28050,CAP,SmPC,en,6.3,Shelf life,28047.0,True
51,28051,CAP,SmPC,en,6.4,Special precautions for storage,28047.0,True
52,28052,CAP,SmPC,en,6.5,Nature and contents of container <and special equipment for use administration or implantation>,28047.0,True
53,28053,CAP,SmPC,en,6.6,Special precautions for disposal <and other handling>,28047.0,True
54,28054,CAP,SmPC,en,,Use in the paediatric population,28053.0,False
55,28055,CAP,SmPC,en,7,MARKETING AUTHORISATION HOLDER,28001.0,True
56,28056,CAP,SmPC,en,8,MARKETING AUTHORISATION NUMBER(S),28001.0,True
57,28057,CAP,SmPC,en,9,DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION,28001.0,True
58,28058,CAP,SmPC,en,10,DATE OF REVISION OF THE TEXT,28001.0,True
59,28059,CAP,SmPC,en,11,DOSIMETRY,28001.0,False
60,28060,CAP,SmPC,en,12,INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS,28001.0,False
1,29001,CAP,AnnexII,en,,ANNEX II,,True
2,29002,CAP,AnnexII,en,A,MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE,29001.0,True
3,29003,CAP,AnnexII,en,,Name and address of the manufacturer(s) of the biological active substance(s),29002.0,False
4,29004,CAP,AnnexII,en,,Name and address of the manufacturer(s) responsible for batch release,29002.0,True
5,29005,CAP,AnnexII,en,B,CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE,29001.0,True
6,29006,CAP,AnnexII,en,,Official batch release,29005.0,False
7,29007,CAP,AnnexII,en,C,OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION,29001.0,True
8,29008,CAP,AnnexII,en,,Periodic safety update reports (PSURs),29007.0,True
9,29009,CAP,AnnexII,en,D,CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT,29001.0,True
10,29010,CAP,AnnexII,en,,Risk management plan (RMP),29009.0,True
11,29011,CAP,AnnexII,en,,Additional risk minimisation measures,29009.0,False
12,29012,CAP,AnnexII,en,,Obligation to conduct post-authorisation measures,29009.0,False
13,29013,CAP,AnnexII,en,E,"SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR
<THE CONDITIONAL MARKETING AUTHORISATION> <THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES>",29001.0,False
1,30001,CAP,Labelling,en,,LABELLING ,,True
2,30002,CAP,Labelling,en,,PARTICULARS TO APPEAR ON <THE OUTER PACKAGING> <AND> <THE IMMEDIATE PACKAGING>,30001.0,True
3,30003,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,30002.0,True
4,30004,CAP,Labelling,en,2,STATEMENT OF ACTIVE SUBSTANCE(S),30002.0,True
5,30005,CAP,Labelling,en,3,LIST OF EXCIPIENTS,30002.0,True
6,30006,CAP,Labelling,en,4,PHARMACEUTICAL FORM AND CONTENTS,30002.0,True
7,30007,CAP,Labelling,en,5,METHOD AND ROUTE(S) OF ADMINISTRATION,30002.0,True
8,30008,CAP,Labelling,en,6,SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN,30002.0,True
9,30009,CAP,Labelling,en,7,"OTHER SPECIAL WARNING(S), IF NECESSARY",30002.0,True
10,30010,CAP,Labelling,en,8,EXPIRY DATE,30002.0,True
11,30011,CAP,Labelling,en,9,SPECIAL STORAGE CONDITIONS,30002.0,True
12,30012,CAP,Labelling,en,10,"SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",30002.0,True
13,30013,CAP,Labelling,en,11,NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER,30002.0,True
14,30014,CAP,Labelling,en,12,MARKETING AUTHORISATION NUMBER(S) ,30002.0,True
15,30015,CAP,Labelling,en,13,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",30002.0,True
16,30016,CAP,Labelling,en,14,GENERAL CLASSIFICATION FOR SUPPLY,30002.0,True
17,30017,CAP,Labelling,en,15,INSTRUCTIONS ON USE,30002.0,True
18,30018,CAP,Labelling,en,16,INFORMATION IN BRAILLE,30002.0,True
19,30019,CAP,Labelling,en,17,UNIQUE IDENTIFIER – 2D BARCODE,30002.0,True
20,30020,CAP,Labelling,en,18,UNIQUE IDENTIFIER - HUMAN READABLE DATA,30002.0,True
21,30021,CAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS,30001.0,True
22,30022,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,30021.0,True
23,30023,CAP,Labelling,en,2,NAME OF THE MARKETING AUTHORISATION HOLDER,30021.0,True
24,30024,CAP,Labelling,en,3,EXPIRY DATE,30021.0,True
25,30025,CAP,Labelling,en,4,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",30021.0,True
26,30026,CAP,Labelling,en,5,OTHER,30021.0,True
27,30027,CAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS,30001.0,True
28,30028,CAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION,30027.0,True
29,30029,CAP,Labelling,en,2,METHOD OF ADMINISTRATION,30027.0,True
30,30030,CAP,Labelling,en,3,EXPIRY DATE,30027.0,True
31,30031,CAP,Labelling,en,4,"BATCH NUMBER<, DONATION AND PRODUCT CODES>",30027.0,True
32,30032,CAP,Labelling,en,5,"CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",30027.0,True
33,30033,CAP,Labelling,en,6,OTHER,30027.0,True
1,31001,CAP,Package leaflet,en,,PACKAGE LEAFLET,,True
2,31002,CAP,Package leaflet,en,,q This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.,31001.0,False
3,31003,CAP,Package leaflet,en,,What is in this leaflet,31001.0,True
4,31004,CAP,Package leaflet,en,1,What X is and what it is used for,31001.0,True
5,31005,CAP,Package leaflet,en,2,What you need to know before you <take> <use> X ,31001.0,True
6,31006,CAP,Package leaflet,en,,Do not <take> <use> X,31005.0,True
7,31007,CAP,Package leaflet,en,,Warnings and precautions ,31005.0,True
8,31008,CAP,Package leaflet,en,,Children <and adolescents>,31005.0,True
9,31009,CAP,Package leaflet,en,,Other medicines and X,31005.0,True
10,31010,CAP,Package leaflet,en,,"X with <food> <and> <,> <drink> <and> <alcohol>",31005.0,True
11,31011,CAP,Package leaflet,en,,"Pregnancy <and> <,> breast-feeding <and fertility>",31005.0,True
12,31012,CAP,Package leaflet,en,,Driving and using machines,31005.0,True
13,31013,CAP,Package leaflet,en,,X contains {name the excipient(s)},31005.0,False
14,31014,CAP,Package leaflet,en,3,How to <take> <use> X ,31001.0,True
15,31015,CAP,Package leaflet,en,,Use in children <and adolescents>,31014.0,False
16,31016,CAP,Package leaflet,en,,If you <take> <use> more X than you should,31014.0,False
17,31017,CAP,Package leaflet,en,,If you forget to <take> <use> X>,31014.0,False
18,31018,CAP,Package leaflet,en,,If you stop <taking> <using> X>,31014.0,False
19,31019,CAP,Package leaflet,en,4,Possible side effects,31001.0,True
20,31020,CAP,Package leaflet,en,,Additional side effects in children <and adolescents>,31019.0,False
21,31021,CAP,Package leaflet,en,,Reporting of side effects,31019.0,True
22,31022,CAP,Package leaflet,en,5,How to store X,31001.0,True
23,31023,CAP,Package leaflet,en,6,Contents of the pack and other information,31001.0,True
24,31024,CAP,Package leaflet,en,,What X contains ,31023.0,True
25,31025,CAP,Package leaflet,en,,What X looks like and contents of the pack,31023.0,True
26,31026,CAP,Package leaflet,en,,Marketing Authorisation Holder <and Manufacturer>,31023.0,True
27,31027,CAP,Package leaflet,en,,"For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:",31023.0,False
28,31028,CAP,Package leaflet,en,,This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.,31023.0,True
29,31029,CAP,Package leaflet,en,,Other sources of information,31023.0,False
30,31030,CAP,Package leaflet,en,,The following information is intended for healthcare professionals only:,31001.0,False
1,32001,NAP,SmPC,en,,SUMMARY OF PRODUCT CHARACTERISTICS,,True
2,32002,NAP,SmPC,en,,qThis medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.>,32001.0,False
3,32003,NAP,SmPC,en,1,NAME OF THE MEDICINAL PRODUCT,32001.0,True
4,32004,NAP,SmPC,en,2,QUALITATIVE AND QUANTITATIVE COMPOSITION,32001.0,True
5,32005,NAP,SmPC,en,,Excipient(s) with known effect,32004.0,False
6,32006,NAP,SmPC,en,3,PHARMACEUTICAL FORM,32001.0,True
7,32007,NAP,SmPC,en,4,CLINICAL PARTICULARS,32001.0,True
8,32008,NAP,SmPC,en,4.1,Therapeutic indications,32007.0,True
9,32009,NAP,SmPC,en,4.2,Posology and method of administration,32007.0,True
10,32010,NAP,SmPC,en,,Posology,32009.0,True
11,32011,NAP,SmPC,en,,Paediatric population,32010.0,True
12,32012,NAP,SmPC,en,,Method of administration ,32009.0,True
13,32013,NAP,SmPC,en,,Precautions to be taken before handling or administering the medicinal product,32012.0,False
14,32014,NAP,SmPC,en,4.3,Contraindications,32007.0,True
15,32015,NAP,SmPC,en,4.4,Special warnings and precautions for use,32007.0,True
16,32016,NAP,SmPC,en,,Traceability,32015.0,False
17,32017,NAP,SmPC,en,,Paediatric population,32015.0,False
18,32018,NAP,SmPC,en,4.5,Interaction with other medicinal products and other forms of interaction,32007.0,True
19,32019,NAP,SmPC,en,,Paediatric population,32018.0,False
20,32020,NAP,SmPC,en,4.6,"Fertility, pregnancy and lactation",32007.0,True
21,32021,NAP,SmPC,en,,Pregnancy,32020.0,False
22,32022,NAP,SmPC,en,,Breast-feeding,32020.0,False
23,32023,NAP,SmPC,en,,Fertility,32020.0,False
24,32024,NAP,SmPC,en,4.7,Effects on ability to drive and use machines,32007.0,True
25,32025,NAP,SmPC,en,4.8,Undesirable effects,32007.0,True
26,32026,NAP,SmPC,en,,Paediatric population,32025.0,False
27,32027,NAP,SmPC,en,,Reporting of suspected adverse reactions,32025.0,True
28,32028,NAP,SmPC,en,4.9,Overdose,32007.0,True
29,32029,NAP,SmPC,en,,Paediatric population,32028.0,False
30,32030,NAP,SmPC,en,5,PHARMACOLOGICAL PROPERTIES,32001.0,True
31,32031,NAP,SmPC,en,5.1,Pharmacodynamic properties,32030.0,True
32,32032,NAP,SmPC,en,,Mechanism of action,32031.0,False
33,32033,NAP,SmPC,en,,Pharmacodynamic effects,32031.0,False
34,32034,NAP,SmPC,en,,Clinical efficacy and safety,32031.0,False
35,32035,NAP,SmPC,en,,Paediatric population,32031.0,False
36,32036,NAP,SmPC,en,5.2,Pharmacokinetic properties,32030.0,True
37,32037,NAP,SmPC,en,,Absorption,32036.0,False
38,32038,NAP,SmPC,en,,Distribution,32036.0,False
39,32039,NAP,SmPC,en,,Biotransformation,32036.0,False
40,32040,NAP,SmPC,en,,Elimination,32036.0,False
41,32041,NAP,SmPC,en,,Linearity/non-linearity,32036.0,False
42,32042,NAP,SmPC,en,,Pharmacokinetic/pharmacodynamic relationship(s),32036.0,False
43,32043,NAP,SmPC,en,5.3,Preclinical safety data,32030.0,True
44,32044,NAP,SmPC,en,,Environmental risk assessment (ERA),32043.0,False
45,32045,NAP,SmPC,en,6,PHARMACEUTICAL PARTICULARS,32001.0,True
46,32046,NAP,SmPC,en,6.1,List of excipients,32045.0,True
47,32047,NAP,SmPC,en,6.2,Incompatibilities,32045.0,True
48,32048,NAP,SmPC,en,6.3,Shelf life,32045.0,True
49,32049,NAP,SmPC,en,6.4,Special precautions for storage,32045.0,True
50,32050,NAP,SmPC,en,6.5,Nature and contents of container,32045.0,True
51,32051,NAP,SmPC,en,6.6,Special precautions for disposal <and other handling>,32045.0,True
52,32052,NAP,SmPC,en,,Use in the paediatric population,32051.0,False
53,32053,NAP,SmPC,en,7,MARKETING AUTHORISATION HOLDER,32001.0,True
54,32054,NAP,SmPC,en,8,MARKETING AUTHORISATION NUMBER(S),32001.0,True
55,32055,NAP,SmPC,en,9,DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION,32001.0,True
56,32056,NAP,SmPC,en,10,DATE OF REVISION OF THE TEXT,32001.0,True
57,32057,NAP,SmPC,en,11,DOSIMETRY,32001.0,False
58,32058,NAP,SmPC,en,12,INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS,32001.0,False
1,33001,NAP,Labelling,en,,LABELLING ,,True
2,33002,NAP,Labelling,en,,PARTICULARS TO APPEAR ON <THE OUTER PACKAGING> <AND> <THE IMMEDIATE PACKAGING>,33001.0,True
3,33003,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,33002.0,True
4,33004,NAP,Labelling,en,2,STATEMENT OF ACTIVE SUBSTANCE(S),33002.0,True
5,33005,NAP,Labelling,en,3,LIST OF EXCIPIENTS,33002.0,True
6,33006,NAP,Labelling,en,4,PHARMACEUTICAL FORM AND CONTENTS,33002.0,True
7,33007,NAP,Labelling,en,5,METHOD AND ROUTE(S) OF ADMINISTRATION,33002.0,True
8,33008,NAP,Labelling,en,6,SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN,33002.0,True
9,33009,NAP,Labelling,en,7,"OTHER SPECIAL WARNING(S), IF NECESSARY",33002.0,True
10,33010,NAP,Labelling,en,8,EXPIRY DATE,33002.0,True
11,33011,NAP,Labelling,en,9,SPECIAL STORAGE CONDITIONS,33002.0,True
12,33012,NAP,Labelling,en,10,"SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",33002.0,True
13,33013,NAP,Labelling,en,11,NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER,33002.0,True
14,33014,NAP,Labelling,en,12,MARKETING AUTHORISATION NUMBER(S) ,33002.0,True
15,33015,NAP,Labelling,en,13,BATCH NUMBER,33002.0,True
16,33016,NAP,Labelling,en,14,GENERAL CLASSIFICATION FOR SUPPLY,33002.0,True
17,33017,NAP,Labelling,en,15,INSTRUCTIONS ON USE,33002.0,True
18,33018,NAP,Labelling,en,16,INFORMATION IN BRAILLE,33002.0,True
19,33019,NAP,Labelling,en,17,UNIQUE IDENTIFIER – 2D BARCODE,33002.0,True
20,33020,NAP,Labelling,en,18,UNIQUE IDENTIFIER - HUMAN READABLE DATA,33002.0,True
21,33021,NAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS,33001.0,True
22,33022,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT,33021.0,True
23,33023,NAP,Labelling,en,2,NAME OF THE MARKETING AUTHORISATION HOLDER,33021.0,True
24,33024,NAP,Labelling,en,3,EXPIRY DATE,33021.0,True
25,33025,NAP,Labelling,en,4,BATCH NUMBER,33021.0,True
26,33026,NAP,Labelling,en,5,OTHER,33021.0,True
27,33027,NAP,Labelling,en,,MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS,33001.0,True
28,33028,NAP,Labelling,en,1,NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION,33027.0,True
29,33029,NAP,Labelling,en,2,METHOD OF ADMINISTRATION,33027.0,True
30,33030,NAP,Labelling,en,3,EXPIRY DATE,33027.0,True
31,33031,NAP,Labelling,en,4,BATCH NUMBER,33027.0,True
32,33032,NAP,Labelling,en,5,"CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",33027.0,True
33,33033,NAP,Labelling,en,6,OTHER,33027.0,True
1,34001,NAP,Package leaflet,en,,PACKAGE LEAFLET,,True
2,34002,NAP,Package leaflet,en,,q This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.,34001.0,False
3,34003,NAP,Package leaflet,en,,What is in this leaflet,34001.0,True
4,34004,NAP,Package leaflet,en,1,What X is and what it is used for,34001.0,True
5,34005,NAP,Package leaflet,en,2,What you need to know before you <take> <use> X ,34001.0,True
6,34006,NAP,Package leaflet,en,,Do not <take> <use> X,34005.0,True
7,34007,NAP,Package leaflet,en,,Warnings and precautions ,34005.0,True
8,34008,NAP,Package leaflet,en,,Children <and adolescents>,34005.0,True
9,34009,NAP,Package leaflet,en,,Other medicines and X,34005.0,True
10,34010,NAP,Package leaflet,en,,"X with <food> <and> <,> <drink> <and> <alcohol>",34005.0,True
11,34011,NAP,Package leaflet,en,,"Pregnancy <and> <,> breast-feeding <and fertility>",34005.0,True
12,34012,NAP,Package leaflet,en,,Driving and using machines,34005.0,True
13,34013,NAP,Package leaflet,en,,X contains {name the excipient(s)},34005.0,False
14,34014,NAP,Package leaflet,en,3,How to <take> <use> X ,34001.0,True
15,34015,NAP,Package leaflet,en,,Use in children <and adolescents>,34014.0,False
16,34016,NAP,Package leaflet,en,,If you <take> <use> more X than you should,34014.0,False
17,34017,NAP,Package leaflet,en,,If you forget to <take> <use> X>,34014.0,False
18,34018,NAP,Package leaflet,en,,If you stop <taking> <using> X>,34014.0,False
19,34019,NAP,Package leaflet,en,4,Possible side effects,34001.0,True
20,34020,NAP,Package leaflet,en,,Additional side effects in children <and adolescents>,34019.0,False
21,34021,NAP,Package leaflet,en,,Reporting of side effects,34019.0,True
22,34022,NAP,Package leaflet,en,5,How to store X,34001.0,True
23,34023,NAP,Package leaflet,en,6,Contents of the pack and other information,34001.0,True
24,34024,NAP,Package leaflet,en,,What X contains ,34023.0,True
25,34025,NAP,Package leaflet,en,,What X looks like and contents of the pack,34023.0,True
26,34026,NAP,Package leaflet,en,,Marketing Authorisation Holder and Manufacturer,34023.0,True
27,34027,NAP,Package leaflet,en,,This medicinal product is authorised in the Member States of the EEA under the following names :,34023.0,False
28,34028,NAP,Package leaflet,en,,This leaflet was last revised in <{MM/YYYY}><{month YYYY}>.,34023.0,True
29,34029,NAP,Package leaflet,en,,Other sources of information,34023.0,False
30,34030,NAP,Package leaflet,en,,The following information is intended for healthcare professionals only:,34001.0,False
